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ABSTRACT FOR THE DISSERTATION TO BE SUBMITTED TO                          
THE TAMILNADU Dr M.G.R MEDICAL UNIVERSITY, CHENNAI  
FOR APRIL 2015 M.D.FORENSIC MEDICINE EXAMINATIONS 
TITLE: STUDY OF THE SERO - PREVALENCE OF HEPATITIS B VIRUS IN        
              MEDICO LEGAL AUTOPSIES 
Abstract:  
Medico - legal practice is associated with a significantly increased risk 
when compared to other medical specialties, both in terms of airborne and blood 
borne diseases. However, the availability of data regarding these potential 
occupational risks is limited. Safety becomes an issue, both in medical and 
ecological aspects regarding the protection of environment with the high 
seroprevalence of HIV and hepatitis viruses. Hepatitis B virus has the highest 
transmissibility rate with a rate of about 100 times greater than HIV. Hepatitis B 
virus is associated with an increased morbidity and mortality among the mortuary 
workers due to its high frequency among the deceased and longevity of the virus. 
Till now only a few retrospective data about the post- mortem behavior of 
serological parameters of HBV, HCV and HIV parameters over time exist. The 
testing of postmortem sera for HbsAg will be a most reliable measure of 
antemortem HBV infection. HbsAg and anti -HbsAg have been shown to remain 
detectable in postmortem serum stored for relatively long periods of time. We 
conducted the Study to find the seroprevalence of HBV in routine autopsy cases.  
Materials and methods: The study sample consists of 515 routine autopsy cases 
at Institute of Forensic Medicine, Madras Medical College. The samples were 
tested using a Human enzyme linked immunoassay kit for the presence of 
HBsAg. 
Conclusion: Out of 515 cases, there are eighteen positive cases and thirteen 
positive cases were male, four positive cases were female and one case was 
transgender. The presence of 18 positive cases among 515 cases, though 
statistically insignificant is higher than many other voluntary screening programs. 
This shows that HBV screening is of great importance among the community. 
The present study concludes that testing of HBV in medico legal autopsies is a 
convenient and effective method in monitoring the surveillance of HBV-infection 
in the general population and it can be used for epidemiological studies. This 
screening test for the HBsAg may not be sensitive if the person was in the window 
period. It could be used along with unlinked anonymous tests from hospital and 
other similar patient materials. 
  
Keywords: Hepatitis B, Viral hepatitis, Autopsy, HBsAg, Screening test  
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INTRODUCTION 
Autopsy examination as an important tool for research, medical 
education, identification of new diseases or new manifestations of already 
known diseases, quality control in clinical service and evaluation of the 
effectiveness of therapeutic strategies, as well as for establishing the 
cause of death was mentioned in various studies by various authors1,2,3 
Since the beginning of the last century the value of medico legal or 
pathological autopsy for detecting incorrect diagnoses and as an 
instrumental tool for quality control of medical health care has been 
confirmed by various studies4,5,6. 
Autopsies were conducted on an average of 50% of deaths in 
1940s, but less than 10% in the 1990s, and these statistics were applied 
both at the level of universities and community hospitals, and in both the 
developed and most developing countries7,8,9.  
The decreasing numbers of medico legal autopsies have had many 
repercussions on the systematic errors and bias in the research data. As 
the data provided in the death certificates are the basis of epidemiology 
and health statistics, they need to be more accurate. Many decisions 
regarding public health are made based on incorrect or incomplete 
information they obtained from the hospital records about the main 
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diagnoses and causes of death, as in most of the cases it was established 
without any autopsy records10. 
Autopsy rates have fallen over the last few decades in spite of the 
overwhelming scientific evidence of the merits of the postmortem 
medical examination in modern medical practice11, 12, 13 
Furthermore, it is the role of the autopsy surgeon to identify the 
dead body subjected for post mortem work and he has to arrive at the 
cause for the death by doing a detailed dissection of the tissues which are 
often in various stages of decomposition14. 
Despite the precautions taken to control the infection and 
availability of various vaccines, the health care professionals who had 
engaged themselves in the medical and medico legal practice are at risk 
of acquiring blood-borne viral infections by exposing them to body 
tissues or body fluids which are often loaded with infectious pathogens, 
irrespective of the stage of human remains. 
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AIMS AND OBJECTIVES 
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AIMS AND OBJECTIVES 
 
Primary Objective: To study the Sero - Prevalence of Hepatitis B virus 
in Medico Legal Autopsies. 
 
Secondary Objectives:  
 To analyze the risk ratio and create awareness among the heath 
care personnel who handles dead bodies 
 To diagnose the clinically undetected   HBV cases. 
 To determine whether postmortem of dead bodies which are 
thought to be at low risk groups, are safe or not. 
 To formulate guidelines for a policy concerning HBV screening 
in forensic autopsy cases 
 To identify the Sero prevalence of HBV in autopsy room 
personnel 
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HIGH-RISK AUTOPSY 
In general, all medico legal or pathological autopsies are of high 
risk nature only. The infectivity status of the deceased person was not 
known in majority of the cases subjected for autopsy, as said before. It is 
well known that dissecting rooms and forensic laboratories are high-risk 
areas for acquiring infection, and forensic staffs have the risk of 
occupational exposure to these infectious agents, especially during post-
mortem investigations. 
Definition: The Postmortem examination of a deceased person who 
has had, or is likely to have had, a serious infectious disease that can be 
transmitted to those who present at the autopsy, thereby causing them 
serious illness and/or premature death15.  
The individuals who ignores, or ignorant of, the potential hazards 
at necropsy are liable not only to themselves but also to the colleagues 
working in or visiting to the mortuary or handling the dead bodies or 
biological material derived from it after autopsy. 
An autopsy may subject the prosecutors and others to a wide 
variety of infectious agents, including blood borne and aerosolized 
pathogens such as human immunodeficiency virus, hepatitis B and C 
viruses, and Mycobacterium tuberculosis. Other hazards which are 
included in this are toxic chemicals (e.g., formalin, cyanide, and 
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organophosphates) and radiation from radio nuclides which are used for 
diagnosis and therapy 16. 
Medico -legal practice is associated with a significantly increased 
risk when compared to other medical specialties, both in terms of 
airborne and blood borne diseases; several studies revealed the increased 
prevalence of hepatitis B, C, D, G, tuberculosis, HIV, prion diseases, 
hantavirus, measles, HTLV-1 or bacterial infections in mortuary 
workers17. 
As infections caused by pathogens such as Mycobacterium 
tuberculosis, HBV, HIV etc are frequently asymptomatic when the 
deceased was alive and without morphological evidence but with retained 
infectivity when brought for necropsy18.  
However, the availability of data regarding these potential 
occupational risks is limited. Safety becomes an issue, both in medical 
and ecological aspects regarding the protection of environment with the 
high seroprevalence of HIV and hepatitis viruses19. 
The highest rate of laboratory- acquired air borne and blood borne 
infections from the dead bodies was seen in autopsy workers which was 
also established by the studies conducted between 1970 and 1989 in 
British clinical laboratories20. 
Airborne, contact routes and sharp instrument or needle injuries 
spread these infections from the corpses to workers 15,21,22,23 . However, in 
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many forensic situations the statistical risk of hepatitis and HIV infection 
are markedly greater than in the general autopsy population when they 
involve homosexuals and drug abusers23. 
HEPATITIS B VIRUS 
Hepatitis B virus has a global distribution24,25 .More than 240 
million people have chronic (long-term) liver infections. About 600 000 
people die every year due to the acute or chronic consequences of 
hepatitis B. The World Health Organization (WHO) considers hepatitis B 
virus (HBV) to be second to tobacco among the carcinogens26 
Hepatitis B Virus, Hepatitis C Virus, as well as HIV, are the major 
sources of worldwide public health concern15,21. Amongst all the 
parenteral viruses, Hepatitis B virus has the highest transmissibility rate 
with a rate of about 100 times greater than HIV. It can lead to an acute 
infection, with a high chance of complete recovery or a latent infection 
with an increased risk of chronicity and hepatocellular carcinoma.  
Hepatitis B virus is associated with an increased morbidity and 
mortality among the mortuary workers due to its high frequency among 
the deceased and longevity of the virus14.HBV, HCV and HIV share 
similar modes of transmission and are relatively frequent among certain 
high- risk groups.  
The increased duration in the profession increases the prevalence 
rate among the health care workers with 30% in those with 20 or more 
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years of duration in their profession and 5%in the general population in 
persons of comparable age27.  
When compared to physicians, the pathologists are considered as a 
high-risk group for occupationally acquired HBV infection due to their 
exposure to blood and body fluids28.  
Studies conducted in US found the highest risk for HBV infection 
was amongst surgeons and pathologists (about 6%)28.  
Study showed that the technicians having 8.8% of hepatitis B 
positivity due to his direct contact with blood while doing his 
professional work. Surveillance of health care workers or forensic 
medicine personnel suffering sharp injuries suggests that the presence of 
'e' antigen (HBeAg) in the contaminating blood increases the overall risk 
of acquiring infection from 5% to 30%29.  
CDC also noticed the similar increased risk of acquiring infection 
from 5% to 30% if the blood is contaminated with HBe antigen30 
The highest risk is noted among the nurses/ auxiliary personnel31; 
for example in Austr [p099ia there were identified the following relative 
risks: nurses – 30.6%, auxiliary personnel - 30.4%, physicians – 13.9%, 
laboratory personnel 2.9% and other 22.3%32.   
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PREVIOUS RESEARCH STUDIES DONE IN DEAD BODIES 
WITH REFERENCE TO HBV AND OTHER BLOOD BORNE 
INFECTIONS 
In one study of forensic autopsy cases, 32.6% had serological 
evidence of a significant viral infection and about 84%of known drug 
abusers were found to have at least one viral infection14. 
Zou et al., 2004.based on the investigations have shown that the 
rates of hepatitis B virus (HBV), human immunodeficiency virus (HIV), 
and hepatitis C virus (HCV) infections of tissue found higher in cadaveric 
donors than the first-time blood donors but lower than the normal general 
population 
Yao et al. (2008) observed the musculoskeletal donors in Australia 
for viral infection and found that the incidence and prevalence of Human 
immune deficiency virus, Hepatitis B Virus and Syphilis among post-
mortem bone donors was higher than that of the organ donors33. 
Yao et al., 2007showed similar results in his study of 12415 
musculoskeletal tissue donors in Australia34. He also demonstrated the 
elevated incidence and prevalence of HIV, HCV and HBV infection in 
musculoskeletal donors than first time blood donors33 
In live individuals if the donor was in the window period the result 
will come as false negative, but we can repeat the test by collecting the 
sample from the donor after a gap of 6 months and eliminate the previous 
12 
 
result and confirm the positivity but this chance of doing repeat test was 
not at all possible in our routine autopsies which undoubtedly leads to an 
increased risk in addition to the risk of testing the samples collected from 
the dead body in suboptimal fasion33. 
Weed and Baggenstoss, 1951; Brown et al., 1986; Roth et al., 
1992; De Craemer, 1994; Healing et al., 1995; Kappel et al.,1996; 
Catteneo et al., 1999 stated in his study that the infectious pathogens 
which include Mycobacterium tuberculosis, hepatitis B and C viruses, 
HIV, and prions that cause transmissible spongiform encephalopathies in 
the cadavers present particular risks35. 
Barnett et al., 2001 stated in his study that specific serologic 
markers of hepatitis B and C viruses can be detected in cadaveric tissue 
banks (hepatitis B surface Ag 18.1% and hepatitis C Ab 14.3%35  
Roth et al., 1992 stated the presence of specific serologic markers 
of hepatitis B and C viruses in postmortem blood tests for body donation 
programs35 
Budka et al., 1995; Healing et al.,1995 stated the use of 
nonpermeable, disposable plastic sheet or similar material to avoid 
contamination of the dissection table35. 
Carolin et al conducted “A prospective time - course study on 
serological testing for human immunodeficiency virus, hepatitis B virus 
and hepatitis C virus with blood samples taken up to 48 h after death,” as 
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such study do not exist at that time. The main objective of his prospective 
study was to investigate the post-mortem progression of serological 
parameters for HIV, HBV and HCV over time. The results of his study 
indicate a high post-mortem stability of antibodies and antigens. The low 
anti-HBc titres and probably the test- dependent discrepancies might be 
the possible reasons. EU Directive 2006/17/EC suggested that post-
mortem blood samples should be collected within 24 hours. Till now only 
a few retrospective data about the post- mortem behavior of serological 
parameters of HBV, HCV and HIV parameters over time exist36. The post 
mortem samples should be centrifuged and stored at 2–6 oC without 
delay34. The post-mortem stability of these serological para- meters up to 
48 hours increases the possible number of donors which can be used for 
transplantation. 
Challine et al. (2006) correlated the post-mortem blood sampling 
time and macroscopic abnormal findings (especially haemolysis, and 
icteric or turbid sera) in his study on the post-mortem sampling interval 
(12, 12–24, 24– 36 and 36 hours) showed the significant increase in false-
positive findings especially for HBsAg and anti-HIV and the increased 
retesting rate due to discrepant results in abnormal macroscopy and 
discarding of corneae. However, the post-mortem blood sampling time 
does not determine neither the prevalence of positive results nor their 
accuracy. Based on this study, the post-mortem blood sample timing has 
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no significant influence on the accuracy of the results. Due to the high 
number of false- positive results and the macroscopic serum changes 
authors recommended 12 h maximum time for drawing post-mortem 
blood samples. 
Contrary to the findings of Challine et al. (2006) and Heim et al. 
(1999), Carolin Edleret al noted minimal haemolysis when samples 
were collected after 36 h and moderate to severe haemolysis when 
samples were collected after 48 h of death but he neither found false-
positive nor found false- negative results up to 48 h post-mortem in all his 
samples34.  
Li, Zhang, Constantine et al (1993)37  studied and analyzed the 
risk factors connected with the Seroprevalence of HBV, HCV, HIV-1 in 
forensic autopsies, using ELISA. Serum samples were tested for HBV, 
HCV, HIV-1, HTLV-I and HTLV-II antibodies in 414 autopsy cases 
successively. Of the 414 cases, about 6% were positive for HIV-1, 23.2% 
for HBV, 19.1% for HCV, and 1.0% for HTLV-I and HTLV-II. In his 
study he established the increased HIV 1 prevalence when compared to 
general population at Maryland. The routine testing only for HIV-1 may 
likely miss other infections like hepatitis C virus or hepatitis B virus. 
Hence this study recommends the routine application of universal 
precautions for all autopsies.  
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Hossein Sanaei-Zadeh (2002)38studied the Seroprevalence of 
HBV, HCV and HIV in autopsies, at Tehran. Postmortem blood samples 
were collected in 173 cases for a period of 1 year, out of which 8 were 
positive for Hbs Ag and 7 cases were also positive for Hbs Ag and anti-
HCV. No case was positive for anti-HIV 1 and HIV 2.  He concluded that 
the medico legal autopsy cases which we thought to be at low risk are not 
so and must be considered as both highly and dangerously infectious. 
Hence universal precaution must be carried out during autopsies. 
Eriksen MB et al (2009)39collected the autopsy blood samples 
from the drug addicts in Denmark and screened them by polymerase 
chain reaction (PCR) technique for HIV antibodies and hepatitis 
antibodies with rapid kits and reported the Postmortem Detection of HIV 
genome in about 40% of samples and Hepatitis B virus genome in about 
20% of anti-HBc – positive/anti-HBs-negative samples. 
Weston, J. and Locker et tal40 in his study after assessing 44 
postmortem of adults noticed a significant number (8.3%) of glove 
punctures, out of which 31.8% went unnoticed. Although we know that 
gloves are impermeable to HIV and HBV infection, punctured gloves are 
not so. The results of this study showed that evisceration technique which 
is the first procedure in our routine autopsy techniques is an especially 
risky procedure in terms of glove puncture. As the personnel with 
preexisting hand lesion may be bathed in the infected material for several 
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hours due to the rent in gloves and was never treated according to current 
safety measures. The risk of contamination from the puncture associated 
with concurrent injury is lesser than puncture without concurrent injury, 
as it may be noticed immediately and attended promptly as per the 
universal guidelines. The habit of frequent change of gloves and hand 
washing throughout the procedure and also at the end of procedure is the 
most important way of reducing the infection associated with glove 
puncture 
Li et al37 and Plessis et al41 in their study in forensic autopsy 
performers reported the prevalence of hepatitis B and HIV as 23 and 8% 
respectively. The purpose of their study is to determine whether autopsies 
of the corpses which have been presumed so far to be of low risk group 
are safe or not. HBV has more transmissibility rate as blood borne and as 
aerosol than HIV. As there was limited data available regarding these 
risks to forensic medical personnel who are exposed daily to large 
numbers of severely traumatized bodies in Iran they conducted a research 
to identify the seroprevalence of these viruses in a low risk forensic 
autopsy population in Tehran, the capital of Iran38 
Healing et al., 1995 in his study stated that the cadaver handling 
workers are exposed to a number of infectious agents42.   
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Rischetelli et al, 2001 in his study stated that most likely 
infections are those produced by blood born viruses, enteric pathogens 
and mycobacterium tuberculosis42.   
Curti and Biran, 2001 in his study stated that a strong aversion to 
dead may represent a natural instinct to protect our self against the 
disease42.  
De .ville, 1980 in his study stated that the microorganisms involved 
in the decay process are not always pathogenic42.  
Morgan, 2004 stated that the belief that the dead bodies are 
infectious can be considered as natural reactions by the persons to protect 
themselves from disease42. 
Kermode et al. examined the occupational exposure to blood and 
the risk of blood-borne virus infection among health-care workers in rural 
India and found that 63% of workers reported at least one percutaneous 
injury in one year when compared to 24% in the US population43, 44 
A study “Risk of infection among primary health workers in the 
Western Development Region, Nepal” suggests that basic health workers 
lack sufficient knowledge of universal precautions. The majority of 
respondents (59%) did not answer universal precaution knowledge 
questions. Only 22% of the workers reported accurate knowledge of 
universal precautions as an effective barrier between health workers and 
patients to prevent the transmission of infections45. 
18 
 
HISTORY 
The earliest record of an epidemic caused by hepatitis B virus was 
made by Lurman in 1885 46. In 1883 an outbreak of smallpox occurred in 
Bremen and 1,289 shipyard employees were vaccinated with lymph from 
other people. Eight months later, 191 of the vaccinated shipyard 
employees became ill with jaundice and were diagnosed as suffering from 
serum hepatitis. Those employees who had been inoculated with different 
batches of lymph remained healthy.  
Lurman's paper which proved that contaminated lymph was the 
source of the outbreak was now regarded as a classical example of an 
epidemiological study. Later in 1909, numerous similar outbreaks were 
reported following the introduction of hypodermic needles that were used 
and more importantly reused for administering Salvarsan for the 
treatment of syphilis. Until 1966 the virus was not discovered when 
Baruch Blumberg who was working at the National Institutes of Health 
(NIH) discovered the Australia antigen (later known to be hepatitis B 
surface antigen or HBsAg) in the blood of Australian aboriginal people47. 
Since 1974, the year in which the research was published by MacCallum, 
the role of virus had been suspected 48] but in 1970 D.S. Dane and others 
discovered the virus particle by electron microscopy.49 By the early 1980s 
the viral genome had been sequence50 and the first vaccines were being 
tested51.  
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INCIDENCE AND EPIDEMIOLOGY 
All over the world more than 33% of the population has been 
estimated to have HBV infection with highest incidence of HBV 
seropositivity (anti-HBsAg) noted in sub-Saharan Africa, the Far-East. 
More than 8% of the populations are found to be infected in northern 
Canada, northern South America, Greenland and Alaska with a lifetime 
risk of infection of more than 60% with infections in childhood. 
About 5% of the populations are chronic carriers of HBV and 
nearly 25% of all carriers develop serious liver diseases such as chronic 
hepatitis, cirrhosis, and primary HCC. Hepatitis B Virus infection causes 
more than one million deaths every year.24, 52, 53, 54  
De Ville, 2000; De Ville de Goyet C 2000 stated that the risk of 
infection in case of hepatitis B depends on infectious status of victim, 
mode of exposure and vaccination status of the exposed individual. In 
many developing countries, prevalence of chronic hepatitis B is around 
8% to 10% (Stop Propagating disaster myths. Lancet, 356:762-64) and 
was high for the pathologists, surgeons and other medical personnel 
exposed to blood.34, 42 
The incidence of the HBsAg carrier state in populations is related 
most importantly to the incidence and age of primary infection52. There is 
a variation ranging from 0.1 to 20% in the HBsAg carrier rate among 
different populations groups all over the world.  
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In areas of low seropositivity where anti-HBsAg antibodies is seen 
in less than 2% of the population , the lifetime risk of HBV infection is 
less than 20% with most infections occurring in adults who are in 
elevated risk groups.  
The highest incidence of the disease is seen among the teenagers 
and young adults in low-risk areas of the world. General population had a 
lower incidence of Hepatitis B Virus infection when compared to certain 
high risk groups which have a higher incidence. Nevertheless, screening 
techniques used in blood donors, improved sterilization procedures used 
for blood derivatives and the availability of newer and effective vaccine 
have lowered substantially the infection risk.24 
 In less than 2% of the US general population, HBsAg 
seropositivity is noted, where as 10-15% of the Asian Americans have 
chronic HBV. In America, 50 % of the children were born to Asian 
Americans mothers with chronic HBV infection. HCC is a leading cause 
of death in Asian Americans. There is no difference in the seropositivity 
between the Asian American and African Americans as both have a 
higher rate. 
According to the CDC, approximately 78,000 people in the US 
were infected by Hepatitis B Virus in 2001 and about 5,000 people die 
per year from Hepatitis B Virus-associated disease. In United States, 1 in 
20 people is infected by HBV at some time in their lives with the highest 
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infection rate being in young adults. About 5% of people infected by 
HBV get a chronic infection and there are more than one million 
Americans with chronic hepatitis B. Up to 25% of chronic HBV infected 
patients will die due to some form of liver disease. In United States the 
acute hepatitis B infections has decreased considerably due to the 
excellent vaccine which are now currently available 
ENDEMICITY 
Primary HBV infections have no seasonal preferences.24, 53 
Hepatitis B is highly endemic in all areas of Africa, Alaska, 
Northern Canada, some parts of South America and parts of Greenland, 
the Eastern Mediterranean area, Eastern Europe, China, South-East Asia, 
and the Pacific Islands, except Japan, Australia and New Zealand with 5 
to 15% chronically infected HBV carriers in most of the above said areas. 
Co existence with HDV is also noticed in some areas where the liver of 
infected patients has got severe damage.52, 55 
The countries such as US has low endemicity and higher mortality 
rate for HBV when compared to Haemophilus influenza b (Hib)( five 
times) and  measles (ten times) before the introduction of routine 
vaccination of children.  
The epidemiological patterns in endemic areas of Asia and Africa 
are different from those seen in Western Europe and North America. 
Transmission from the mother to new born and from to child through 
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close contact is cause for most infections which occur in infants and 
children in these regions. Transmission of virus through skin contact with 
contaminated needles or not following safe injection techniques is also a 
possibility in the above mentioned countries.24, 52 
HBV TRENDS 
HBV has no seasonal trends24. 
The use of contaminated blood or blood products or unsterile 
injections leads to the epidemic spread of HBV infection.  
Most HBV infection in young children is not detected in 
surveillance studies of acute disease as they are asymptomatic. So the 
vaccination coverage data and population-based serological analyses are 
used to assess the effectiveness of vaccination programs implemented in 
infants. The success of the programme and decreased rate of infection is 
indicated by a fall in the prevalence rate of chronic disease 52 
The prevalence of chronic HBV infection has considerably reduced 
even in high endemic areas because of the successful implementation of 
infant immunization programmes.52 
The routine infant immunization which when successfully 
implemented will prevent HBV transmission among all age groups by 
inducing broad population based immunity to HBV infection. But only in 
longer term it will have an effect on the incidence and severe 
consequences of chronic HBV infections56. 
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PREVALENCE 
HBV occurs worldwide.52, 57 
The highest rates of HBsAg carrier rates are found in developing 
countries with primitive or limited medical facilities.52 
In areas of Africa and Asia, widespread HBV infection may occur 
in infancy and childhood and the overall HBsAg carrier rates may be 10 
to 15%.  
The prevalence is lowest in countries with the highest standards of 
living, such as United States, Great Britain, Canada, Scandinavia, and 
some other European Nations.  
In North America, HBV infection is most common in young adults. 
In USA and Canada, serological evidence of previous HBV infection 
varies depending on age and socioeconomic class. Overall, 5% of the 
adult USA population has anti-HBc, and 0.5% is HBsAg positive.  
In developed countries, HBV exposure may be common in certain 
high-risk groups. 
Adult population infected with HBV usually acquires acute 
hepatitis B and recover, but 5 to 10% develop the chronic carrier state. 
Children infected with HBV rarely develop acute disease, but 25 to 90% 
become chronic carriers. About 25% of carriers will die from cirrhosis or 
primary liver cancer as adults.52, 58 
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In the past, there were high risk for HBV infection to the recipients 
of blood and blood products. Over the last 25 years it was made 
mandatory to test the donor blood for the presence of HBsAg which had 
improved the sensitivity to greater extent.  
In 19% of countries routine testing of all blood donations for 
HBsAg was not done according to an unpublished data. The routine and 
systematic screening of blood collected from donors for the presence of 
HBsAg before transfusion reduces the residual risk of HBV transmission 
to a minimum in many countries. The additional viral inactivation and 
removal procedures used for plasma derived medicinal products 
(including antihaemophilic factors) leads to reduction or no HBV 
transmission by these products.  
Inspite of all the necessary precautionary measures taken, the 
developing countries still have the risk of HBV transmission. The 
contaminated needles and  syringes used in clinics or by acupuncturists 
and tattoo parlor may lead to an outbreak of hepatitis B. HBV 
transmission from a HBsAg positive health care workers has also been 
documented rarely.59 
The reduction in Age-related prevalence of HBsAg even in highly 
endemic countries and the adoption of universal immunization of infants 
suggested the possibility of HBV eradication from humans. 
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The use of Hepatitis B vaccines by hundreds of millions of people 
from the year it was available (1982) had and an impact on the disease 
and reduced the prevalence rate of HBV carriers from high to low in 
many countries.  
Fig 1: Geographical Distribution of Prevalence of Hepatitis B 
Infection in 2005 
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FIG 2: Geographical Distribution of Chronic Hepatitis B Virus Infection in 2005 
 
Fig 3: Geographical Distribution of Hepatitis B in 2007 
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Fig 4: Geographical Distribution of Prevalence of Hepatitis B Surface 
Antigen 
 
Fig 5: Geographical Distribution of Chronic HBV Infection 
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HEPATITIS B VIRUS 
Hepatitis B virus (HBV) is a partially double-stranded circular 
DNA virus belongs to the hepadnavirus family and has a DNA genome 
that is replicated via an RNA intermediate. The virus consists of an 
envelope containing the surface antigen (HBsAg) which surrounds the 
viral DNA containing core capsid. During replication of HBV, both the 
whole intact virions and incomplete virus particles consisting entirely of 
HBsAg are produced. 
       Fig 6: Structure of HBV          Fig 7: Electron Microscopy - HBV         
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                      Fig 8: Hepatitis B surface antigen or HBsAg  
 
The envelope of Hepatitis B Virus consist of most important 
protein named as “Hepatitis B surface antigen” or “HBsAg”, which was 
called as Australia antigen in older days. This antigen contains the 
determinant "a", which was common to all known viral subtypes and 
which is immunologically distinguished in two distinct subgroups (ay and 
ad). HBV has 10 major serotypes and four HBsAg subtypes have been 
recognized (adw, ady, ayw, and ayr).  
Components 
It consists of: 
 HBsAg 
 HBcAg (HBeAg is a splice variant) 
 Hepatitis B virus DNA polymerase 
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 HBx. The function of this protein is not yet well known60 but 
evidence suggests it plays a part in the activation of the viral 
transcription process61 
SEROTYPES AND GENOTYPES 
The virus is divided into four major serotypes (adr, adw, ayr, ayw) 
based on antigenic epitopes presented on its envelope proteins, and into 
eight genotypes (A-H) according to overall nucleotide sequence variation 
of the genome. These genotypes have a distinct geographical distribution 
and are used in tracing the evolution and transmission of the HBV. 
Differences between genotypes affect the course and severity of the 
disease, likelihood of developing complications and response to treatment 
and possibly HBV vaccination 62, 63 
Genotypes differ by at least 8% of their sequence and were first 
reported in 1988 when six genotypes were initially described (A-F) 64. 
Two further types (G and H) have since been described.65 Most genotypes 
are now divided into sub genotypes with distinct properties.66 
PATHOLOGY 
As soon as the HBV enters the bloodstream it targets the 
hepatocytes where its receptor found predominantly. The initial dose of 
viral load entering the body decides the rate at which symptoms appear. 
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Even though the viral replication will start only after a few days of initial 
infection, the incubation period ranges from 45-180 days.  
Ground glass appearance in infected cells, the characteristic 
appearance of HBsAg was the first sign of HBV infection. Like other 
hepatitis viruses, Immune-mediated symptoms and also the resolution of 
disease were produced by inflammatory and cell-mediated responses 
which are targeted against the HBsAg which lies on the surface of 
hepatocytes. 
Chronic infection produced by HBV increases the risk of morbidity 
and mortality of the individual from chronic liver disease or primary 
HCC. The initial event which cause the virus to enter the body and the 
onset of symptoms which constitutes loss of appetite, nausea, vomiting, 
abdominal pain, fatigue, jaundice and joint pain was often masked by the 
long incubation period of 6 to 24 weeks67 
Younger the patients, lesser will be the cell-mediated immunity 
and milder the symptoms. Within five years, as a result of lesser immune 
response to HBV, chronic infection develops which subsequently lead to 
chronic hepatitis which in turn leads to development of cirrhosis in up to 
a quarter of patients. Up to 25% of these patients will develop liver 
failure or HCC which are fatal in the absence of a liver transplant. 
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In age group of less than five years about 10% of patients show 
clinical illness (jaundice). In young age group 30-90% of patients 
infected with HBV develop chronic hepatitis. In age group of 5 years and 
above, though 30-50% of patients have symptoms, 30% have no clinical 
symptoms and 2 to 10% will develop chronic hepatitis. 
Fig 9: HEPATITIS B VIRUS REPLICATION 
     
PATHOGENESIS 
After certain period of time which is usually around 30 to 50 years, 
persons who contracted this infection early in their life may develop 
chronic hepatitis, which is usually followed by cirrhosis, and finally 
HCC. Regarding the infection, males when get the infection they usually 
have this infection for long period of time when compared to females. 
Antibodies will develop soon after the infection in case of females.  
33 
 
The main reason for the carcinogenic effect of virus is not the 
direct effect of virus, till now oncogene related to the virus or any 
mutagen is not demonstrated. The possible reason for the occurrence of 
carcinoma in the infected patient is due to the chronic liver disease, after 
the infection there will be inflammatory reactions along with some 
amount of liver damage, when these damages progresses further to 
cirrhosis then the chance for the development of malignancy in that 
particular infected individual is very high53.  
Thus hepatitis B infection alone does not cause the carcinoma, for 
the occurrence of carcinoma the liver damage should accompany 
definitely. This can be proved by, in many healthy persons who are 
carrier for antigen of hepatitis B does not developed carcinoma further 
throughout the life period of time.68 
The liver cells in persons affected with this infection are get injured by 
three various mechanism. 
 When the person infected with hepatitis, our immune system will 
generate cytotoxic T cell, which will act on the various antigens 
which is present on the virus, this will produce a injury on the 
hepatocytes.52,53,57 
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 The antigen within the virus also acts on the liver cells directly 
mainly the core antigen which is considered as other possible 
mechanism.52,53,57 
 Sometimes the antibodies are not secreted in proper quantity, 
which also contributes for the injury of the cell.57 
POST MORTEM STABILITY OF HBV 
Brendan Jacka et al after analyzing the data from his study 
demonstrated the stability of immunoglobulins and albumin in specimens 
collected up to 24 hours port-mortem69.  
Though the concentrations of total protein and albumin were more 
likely to be outside the normal reference range than random living 
controls, there was no correlation between the age of the donor and the 
concentration of any of the biochemical markers. This study also supports 
the stability of serological markers of infection and indicators of plasma 
dilution in cadaveric specimens69. 
In cadaveric specimens, the plasma dilution which may occur as a 
result of autolysis and degradation has been determined to be of little 
consequence and another consideration is the interactions of degraded 
blood components with the serological screening assays employed to 
identify infection. Potential inhibitory effects caused by abnormal 
concentrations of biological substances have been identified in living 
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donors by the manufacturers of serological screening assays - for example 
haemoglobin and bilirubin69.  
As cadaveric specimens may exhibit different levels of biological 
substances, it is necessary to determine if these changes also influence the 
result of serological screening assays. This study is the first reported 
assessment of the test kits, where the clinical and analytical sensitivities 
were found to be equivalent to results from random living donors. While 
these assays were able to detect the presence of serological markers of 
HIV, HCV and HBV infection accurately and reproducibly, there was a 
greater rate of reactivity in initial testing than seen for the general 
population of Sydney69.  
Subsequent confirmatory testing was required to determine 
whether the instances of reactivity were the result of assay interference or 
actual infection. High levels of false-reactivity which have been reported 
when using cadaveric specimens in serological screening, suggests that 
the high rate of initial reactive results seen in this study, are a function of 
the specimen quality69. 
The present study had demonstrated that plasma dilution is not 
occurring in cadaveric specimens collected within24 hours from death, 
and that concentrations of immunoglobulins are relatively stable when 
compared to living donors. 
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Subsequently, accurate and reproducible detection of serological 
markers of infection should be expected when using these assays with 
cadaveric specimens. Accurate reporting of reactive specimens using 
these assays must be further validated using repeat testing and 
confirmatory assays. In conclusion, the safety of transplant recipients 
should be maintained to the current standards of living donors when using 
post-mortem specimens for testing69 
Heim et al. 1999; Miedouge et al. 2002 stated that there will be a 
increased incidence of false seropositivity in post mortem blood samples 
tested for serological markers of viral infection, as the composition of 
blood will change due to potential changes which occur in the vascular 
compartments after death which makes the screening methods used for 
sera from cadaveric organ donors need further validation before testing 
these33. 
Turner et al. 1997 stated that the increased rate of organ rejection 
and reduction in availability of organs for transplantation is due to false-
positivity which are observed in the results of any marker of disease 33 
Singer et al. 2008 stated that he concerned more about the false-
negative results which is to given more importance and eliminated, as it 
creates a false belief about the safety of the donor organ and thus reduces 
the safety for recipients33. 
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Challine et al. 2006 after observing the previous studies he told 
that the immunoassays and NAT assays are inhibited by the presence of 
free Hb in post mortem serum samples 33 
The factors which potentially compromise the sensitivity of post 
mortem serological screening tests:  
(a) Post mortem dilution of the serum in the vascular system 
affecting the detection limits  
(b) Post mortem haemolysis which leads to the release of free Hb 
which in turn inhibits the interaction between Ag-Ab complex 
and reduces the sensitivity and causes false seronegativity  
(c) Post mortem proteolysis and its interference with Ag-Ab 
binding and cause false-positivity.  
So their aim was to define the correlation between the post-mortem 
serum changes and its influence on tests done to detect infection with 
HIV, HCV, HBV, T. Pallidum and HTLV I/II in donors by comparing the 
pre and post-mortem samples analytical performance33. 
Heim et al. 1999 stated about the post mortem biochemical 
changes in blood specimens and the interference of increased free serum 
haemoglobin with the immunoassays which are often used as a 
serological screening modality for infectious disease33 
Heck and Baxter in 1994 and Eastlund in 2000 stated that the 
haemodilution caused by the transfusion of blood and infusion of 
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crystalloids in an effort to save the life during the last hours of life, also 
affects the serological tests done for screening the infectious diseases33 
Eastlund and Schuller1994 contradicts the statement of Heck and 
Baxter and demonstrated that sensitivity of these assays would not be 
affected by resuscitation induced haemodilution as negative results occur 
only when the level of haemodilution is very high which is not normally 
seen in resuscitation33 
This study showed that there was no significant difference between 
antibody and antigen markers in pre mortem and post mortem specimens.  
The results obtained from testing the biochemical parameters in post 
mortem blood suggest that the levels of immunoglobulinlevels (total or 
specific) in the post mortem samples will not be reduced due to the post-
mortem stability of antibodies33 
Kitchen and Newham in 2010 did the first study to analyze the 
sensitivity of the Abbott Architect Analyser by mixing the known 
positive sera with cadaveric sera to make the sample similar to post-
mortem samples. They have also assessed the post mortem changes and 
established the post mortem stability of infectious viral seromarkers up to 
24 h post mortem and made the results more reliabile33. 
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Fig 10: Spectrum of liver disease after HBV infection 
              
The factors correlating the severity of disease are the infecting viral 
dose and the age of the person infected with HBV52, 57. 90% of adult 
population and 10% of new born had transient HBV infection, whereas 
the rest had the persistent infection with HBV but clinically detectable 
only in smaller groups52. Clinical manifestation of jaundice was observed 
in infected children (<10%) and adults (30-50%)70 
Primary infection had a wide range of clinical manifestation 
starting from mild to severe to fulminant with or without liver damage57. 
Majority of the patients having acute infection had sub clinical 
presentation with progression to fulminant damage in less than 1% of 
symptomatic57 .All over the world, Chronic infection of the patients with 
HBV is seen in 350 million people54 .Even though, 33 % of the patients 
with persistent HBV infection had associated cirrhosis and HCC, liver 
function and histology was found to be normal in some cases57. 
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VIRAL MARKERS OF HBV SEEN IN SERUM 
The nature of the viral markers present in the serum of infected patients 
varies with the duration of infection (Acute or Chronic).52, 57, 71 
Table 1 : Serological Viral Markers  
ANTIGENS ANTIBODIES 
 HBsAg 
Earliest indicator of acute infection 
and chronic infection. 
Useful in diagnosis and screening  
 anti-HBs 
Appear 30 to 120days  after 
appearance of symptoms  
Presence indicates clinical recovery 
and development of immunity. 
 HBcAg 
Not detectable in the bloodstream. 
Marker of the infectious viral 
material Most accurate index of 
viral replication.  
 anti-HBc 
Identifies all persons with previous 
infections and HBVcarriers, but it 
cannot differentiate carriers from 
non-carriers 
 HBeAg 
Its presence indicates that the 
patient is infectious and if 
persistent beyond 10 weeks shows 
infectiousness and progression to 
chronic infection.  
 
 anti-HBe 
Its presence is prognostic for 
resolution of HBV infection. 
 
If HBsAg, anti-HBs and core HBV 
mutants are absent in the given 
sample with presence of anti-HBe 
along with anti-HBc, it indicates 
that the patient is of low contagious 
in nature and in convalescence 
phase57. 
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 HBxAg 
Detected in HBeAg positive blood 
in patients with both acute and 
chronic hepatitis 
 anti-HBx 
When other virological markers are 
becoming undetectable, it appears. 
 HBV DNA  
Detected as soon as 1 week after 
the initial infection and used in 
monitoring of the treatment with 
antiviral drugs and to detect 
mutants which the currently 
available methods failed to detect.  
 
 HBV DNA polymerase 
Though detected early (within 1 
week of initial infection) has right 
now no role except for research. 
  
PATTERNS OF VIRAL INFECTION 
All patients exposed to HBV will not react in the same way and hence 
had varied patterns of infection.57 
1. HBsAg-positive Self-limited primary HBV infection  
2. HBsAg-negative Self-limited primary HBV infection  
3. HBsAg-positive persistent HBV infection 
Unusual HBV serological profiles which require further evaluation 
The sample which shows unusual serological profile should be retested or 
new sample to be collected and tested24. 
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Table 2: Unusual Serological Profile and its Interpretation 
Serological Profile Interpretation 
 HBsAg positive and  
anti-HBc negative 
Acute hepatitis B patients in incubation 
period (even before the onset of clinical 
symptoms and biochemical derangements).  
  
 Positive for all the three 
HBsAg   
anti-HBs   
anti-HBc  
 Seen in acute hepatitis B resolution, in 
chronic carriers with serious liver disease or 
in carriers exposed to heterologous subtypes 
of HBsAg. 
Only anti-HBc positive   Infection in the past which was not 
resolved completely 
 HBeAg positive and  
HBsAg negative 
 Not commonly seen 
 Positive for both 
HBeAg and anti-HBe 
 Not commonly seen 
 only anti-HBs positive 
(in a non immunized 
person) 
  
 Those who received  
1. passive transfer of anti-HBs 
following blood transfusion from a 
vaccinated donor 
2. clotting factors 
3. immunoglobulins 
In new born children born to HBV infected 
mothers irrespective of whether the 
infection is recent or past. 
Seen in forgotten immunization status!  
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Clinical phases of acute hepatitis B viral infection 
Acute infection with Hepatitis B virus infection comprises > 90% 
of adult-onset infection. The remaining population of adult-onset 
infection and >90% of new born infection turns to chronic and continue 
for the rest of the life with small percentage of mortality from acute HBV. 
 Patients with acute illness often have an insidious onset with non 
specific symptoms. Jaundice may develop later with or without Pyrexia.24, 
52, 57, 68 
The initial non specific symptoms is followed by the icteric phase 
which manifests through dark appearing urine, pallor of stools and 
yellowish staining of body tissues and fluids within 10 days. Jaundice 
needs the level of total bilirubin in blood to be in excess of 20 to 40 mg/l 
to become clinically apparent. It is accompanied by the enlargement of 
liver and spleen. The disease resolves with the disappearance of jaundice 
and the appearance of antibodies (anti-HBs) after 4-12 weeks of initial 
infection in about 95% of adults24. 
After 4-8 week of acute illness, the disease often resolves 
spontaneously in most patients without any adverse sequel and 
recurrence. Morbidity and mortality is high in elderly persons due to the 
development of fulminating and fatal acute hepatic necrosis. Young 
44 
 
children has the tendency to become chronic carriers if they acquire the 
infection before the age of seven and acute illness will develop rarely in 
them.24, 52, 53, 57, 68 
Serum shows the presence of anti-HBc IgM serum antibodies 
during acute phase and the presence of anti-HBc IgG serum antibodies 
during convalescence and recovery. During the transient period (<6 
months) HBsAg, HBeAg, and viral DNA will be present. During 
seroconversion, viral markers which were present already in the 
circulation will be cleared with the appearance of anti-HBsAg and anti-
HBeAg.  
Though the increase (Mild to Moderate to Severe) in serum 
transaminase levels (ALT) during acute phase is the hallmark of acute 
viral hepatitis, a striking increase does not reflect a poor prognosis.  
The amount of viral load in the inoculum, the mode of virus 
transmission into the host and host factors determines the variability of 
the incubation period from 45 to 120 days (average of 60 to 90 days)24, 52, 
57, 68 
If the large amount of virus enters into the circulation, patients 
develop icteric symptoms early due to the shorter incubation period, 
which is common in transfusion of blood which is already infectious57. 
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No dietary or life style modification is needed in most cases. 
Fig 11: Serological Pattern In Acute Viral Infection 
             
CLINICAL FEATURES OF CHRONIC HEPATITIS B VIRUS 
INFECTION 
 Persistence (>6 months) of HBsAg (with or without concurrent 
HBeAg) is the principal marker for the risk of developing chronic 
liver disease and hepatocellullar carcinoma (HCC) later in life. 
 The presence of HBeAg indicates the highly contagious nature of the 
blood and body fluids of the infected individual  
Low replicative phase:  
This phase is associated with the loss of HBeAg or a decrease or 
loss of the HBV DNA concentrations and with the appearance of anti-
HBe. A decrease in inflammatory activity is evident histologically. 
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Serologic changes like the loss of HBV DNA and HBeAg are referred to 
as seroconversion. 
Non replicative phase:  
Markers of viral replication are either absent or below detection 
level and the inflammation is diminished but if cirrhosis has already 
developed, it may persist indefinitely.   
The laboratory abnormalities consist of elevation of the ALT which 
ranges from normal to 200 IU/l in up to 90% of patients. Transaminases, 
serum bilirubin, albumin, and gamma globulin values are mild to 
markedly elevated. Autoimmune antibodies such as anti-nuclear 
antibody, anti-mitochondrialantibodyand anti-smooth muscle 
antibodymay be present24. 
Sustained increases in the concentrations of the aminotransferases 
together with the presence of HBsAg for >6 months is regarded as 
indicative of chronic hepatitis.  
Progression to fulminant hepatitis B 
Fulminant hepatitis B is a rare but fatal condition caused by 
massive hepatic necrosis which develops in about 1% of cases.24, 52  
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The children had a better prognosis when compared to adults, in 
whom the survival is uncommon and if survived, only a few persons have 
a complete recovery. Permanent damage to the liver and chronicity of 
infection was not noted in the survivors24, 57. 
Those infected with precore mutants often develops severe 
infection and early damage to the liver, in form of chronic hepatitis and 
development of early fulminant hepatic failure72. 
There is an association of genetic heterogeneity of HBV, 
immunological factors of the host, coinfection or super infection with 
other viral hepatitis agents with the development of fulminant hepatitis 
B24, 57. 
In patients with fulminant hepatic failure, as the hepatocytes are 
being lost the rapid fall in ALT and AST should not be interpreted as a 
resolving hepatic infection and the outcome is often fatal71. 
Fig 12: Serological Pattern in Chronic HBV infection (HBeAg positive) 
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Fig 13: Serological Pattern in Chronic HBV infection (HBeAg negative) 
 
 
 
HBV and Cirrhosis 
Fig 14: HPE of Liver in Cirrhosis 
             
Chronic hepatitis B viral infections were one among the 10 leading 
causes of mortality in men. It is estimated that men has 40 – 50% lifetime 
mortality risk from cirrhosis and/or hepatocellular carcinoma which 
develops as a sequel of chronic disease. Women pose lesser risk (15%) 
when compared to men.  
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The liver substance undergoes chronic and wide spread destruction 
leading to development of cirrhosis in up to 20% of the patients with 
chronic persistent hepatitis. The internal structure of the liver in cirrhotic 
patients is grossly deranged in such a way to obstruct the blood flow, 
which cause the liver cells to die with decrease in liver function. The liver 
parenchyma is damaged by recurrent HBV stimulated immune responses 
and was progressively replaced by fibrotic tissue which leads to the 
formation of nodule (micro or macro). As the liver inflammation is 
asymptomatic, patient will be unaware of the inflammatory progression 
and subsequent development of cirrhosis. The presence of HBV DNA 
determines the contagious nature of most of the carriers.  
 HBV and hepatocellular carcinoma (HCC)  
Over Worldwide, it is most common in both the males and females 
with seventh place in the order of frequency in males and ninth place in 
females. There is sexual, racial, geographical and chronological variation 
in the incidence of HCC. In fact, HBV infection may be the cause of over 
80% of primary hepatocellular carcinoma cases worldwide. This is 
particularly the case when the patient is HBeAg-positive.   
HCC is one among the three most common causes of deaths in 
males due to carcinoma in East and South-east Asia57 
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HCC has a higher mortality with more than 500 000 deaths 
annually with male preponderance (M : F = 4:1) throughout the world. In 
a given general geographic area, the HCC and persistent HBV infection 
follows the same frequency in distribution pattern. After analyzing the 
age at which the tumour appears after HBV infection in patients with 
clinically recognized tumours, it was suggested that tumour appears 35 
years after the infection with HBV24, 57.  
Though a number of patients with chronic hepatitis will develop 
hepatocellular carcinoma24, 57, those who acquired the infection in early 
childhood52 are at an increased risk. Though only 5% of cirrhotic patients 
develop HCC, Cirrhosis was noticed in 60 to 90% of HCC patients.24, 53, 57 
In Taiwan where 15% of the population are HBsAg carriers who 
had a 217 times risk of developing hepatocellular carcinoma than that of a 
non-carrier. About 50% of deaths of HBsAg carriers are caused by liver 
cirrhosis or hepatocellular carcinoma when compared to 2% of general 
population. 
The 25 to 60% mean 5-year survival rate which was observed in 
patients whose hepatocytes undergo malignant transformation, which 
leads to the development of  HCC, depends on various parameters such as 
the symptoms, tumour size and its respectability and the presence or 
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absence of α-fetoprotein (AFP). AFP- positive tumours which was not 
resectable have a mean survival rate of 5 months, whereas AFP-negative 
tumours have 10.5 months24. 
HCC can often be detected at a resectable stage in HBsAg carriers 
by liver scanning or ultrasound procedures, when during the serial follow 
up the serum AFP rises significantly above the patient’s own baseline 
(>100 μg/ml)57. This suggests that HBsAg carriers (those above 40 years 
and those with cirrhosis) should have regular (at 6 months intervals) and 
serial serum AFP determinations and ultrasound examinations57. 
Patient often will die if HCC presents clinically, with survival 
period of less than 3 months whereas, if detected early, there are various 
treatment modalities available such as surgery, radiotherapy, and 
chemotherapy to give an 85% cure rate 
Sundaram C et. Al did his study on 206 cases of autopsy livers for 
the presence of hepatitis B surface antigen by orcein staining to find the 
association of hepatocellular carcinoma and cirrhosis with hepatitis B 
surface antigen in Andhra Pradesh State, in South India. Of 114 cases 
of cirrhosis, 67.54% were positive for the antigen. The antigen positivity 
was 100% in macronodular (13 cases), 98.7% in mixed (55 cases) and 
21.74% in micronodular cirrhosis (46 cases). Only 50 out of 58 cases 
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of HCC were associated with cirrhosis. Hepatitis B surface antigen was 
demonstrated in 80% of HCC associated with cirrhosis and in 75% of 
cases of HCC not associated with cirrhosis73. 
          Fig 15 : Hpe of Liver in HCC 
                         
Hepatitis B - Extra hepatic manifestations   
Seen in 10-20% of patients as 
1. Transient serum sickness-like syndrome24, 52, 57 
2. Acute necrotizing vasculitis (polyarteritisnodosa)24  
3. Membranousglomerulonephritis24, 57  
4. Papularacrodermatitis of childhood (Gianotti-Crosti syndrome) 24  
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 TRANSMISSION 
Currently, there are four recognized modes of transmission24, 54 
1. from mother to child at birth (perinatal) 
2. by contact with an infected person (horizontal) 
3. by sexual contact 
4. by parenteral (blood-to-blood) exposure to blood or other infected 
fluids. 
There is considerable variation in the age at which most 
transmission takes place between the areas, countries and continents.  
Though all body fluids which are secreted and excreted from the 
body contains HBsAg, only blood, vaginal and menstrual fluids and 
semen have been shown to be infectious24, 52, 53, 57.  Apart from these, 
other body secretions show low or non-detectable levels of virus. 
HBV transmission occurs by percutaneous and parenteral exposure 
through transfusion of blood or blood products which are not properly 
screened, haemodialysis, sharing of used injection needles which are not 
properly sterilized and injuries produced by contaminated sharp 
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instruments in the hospital and through permucosal exposure to infective 
body fluids24, 52, 57 
Sexual and perinatal HBV transmission usually occurs from oral or 
vaginal mucosal exposure to blood and body fluids which are often 
infectious. In certain areas of south-east Asia and the far East which are 
considered as hyperendemic, transmission in perinatal period is common 
especially when HBsAg carrier mothers are also HBeAg positive.24, 52, 57  
In groups with high HBsAg carrier rates, transmission of infection 
may occur between household contacts, between homosexual or 
heterosexual partners and in toddler-aged children.24, 52 
The food or water contaminated by HBV will not transmit the 
infection. The same way, insects or other vectors has no role in 
transmission of HBV. But there is no convincing evidence to state that 
HBV infections are also airborne and faeces doesn’t contain the active 
virus, as it is inactivated by intestinal mucosal enzymes or enzymes 
derived from the bacterial flora. 924, 57 
Immune globulins, albumin, fibrinolysin and heat-treated 
plasmaprotein fraction are considered to be safe if manufactured in an 
appropriate manner.  
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Indirect inoculation of HBV can occur due to the stability of HBV 
outside the human body for at least 7 days via inanimate objects when 
contacted with intact mucous membranes or open skin57.HBV will retain 
its infectivity even in post-mortem blood. 
Man is the natural reservoir for HBV25. But in about 35% of cases 
the source of HBV infection could not be identified. 
There can be carriers with or without hepatitis.57 
The failure to detect HBsAg in blood does not mean that the person 
is not infectious and not containing infectious virus as infectious HBV 
can still be present in blood of persons having no detectable levels of 
HBsAg74. 
The technique of reusing the same needle and syringes without 
proper sterilization for vaccinating many different children leads to many 
newer HBV infections which can be prevented otherwise.57, 59  
People those who are likely to receive repeated transfusion due to 
their disease nature should be vaccinated against HBV as it is 100 times 
more infectious than HIV25. 
Minimal infecting dose depends upon the genotype of the infective 
strain. For example: A study in chimpanzees showed that one ml of 
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infective blood contains 102 - 109 viral copies; therefore even a 
microscopically blood particle can contain an infecting dose. In that study 
they found one positive reaction for HVB; but the epidemiological survey 
could not identify a positive case in the last week suggesting that the 
positive status of the cadaver was not known during the autopsy, nor was 
suspected17 
13% of embalmers were found positive for anti HBV42. 
A survey of embalmers in the United States showed that needle 
stick injuries were commonly reported and that 13% of embalmers were 
positive for anti-HBV (about twice the rate in a blood donor comparison 
group)75 
The risk of HBV infection was higher among embalmers who have 
worked more than 10 years with relative risk (RR) of 16.2 and those who 
did not routinely wear gloves with relative risk (RR) of 9.8 when 
compared to those who are employed in the city of Boston, RR 4.775. 
Gershan et al, 1998 stated that exposure occur due to direct 
contact with non-intact skin, percutaneous injury from needles and 
mucous membrane exposure from blood or body fluid to eyes, nose and 
mouth42. 
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 Ball et al, 1991 stated that from needle prick, risk of infection for 
hepatitis B is 6-30% having no prior vaccination, hepatitis C 1.8% and 
HIV is 0.5%42 
Table 3: Viral Transmission in HIV HCV and HBV 
 
Diagnosis  
The disease is usually diagnosed clinically by the symptoms which 
the patients manifest, biochemically by the abnormal parameters like 
elevated liver function test and serologically by the presence of viral 
markers (For eg. HbSAg).   
In acute viral hepatitis, testing the patient’s serum showed the anti-
HBcAg (IgM), whose presence distinguishes that from a chronic 
infection. The panel of tests which are normally done as a screening 
procedure for hepatitis B virus infection includes detection of antigen and 
their corresponding antibodies in the blood of infected patients ( HBsAg, 
anti- HBsAg, HBcAg, anti- HBcAg and HBeAg )  
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The infectious nature of the blood sample is determined by 
presence of HBeAg and not by HBsAg, even if present in large amounts.  
The HBsAg antigen which is detected in the earlier period of infection 
subsides with the appearance of anti-HBsAg antibodies which do not rise 
to a detectable level until about eight months after infection. Though the 
anti-HBsAg is formed as a natural immune response of the body in the 
early phase of infection, it forms Ag-Ab complex with HbSAg released 
from the cells infected with HBV and hence not detectable in the serum. 
This period during when neither free HBsAg nor anti-HbsAg can be 
detected is known as the “HBsAg window” which lasts for about six to 
eight months. The best tool for diagnosis of an acute HBV infection 
during the window is the presence of anti-HBc IgM as only a smaller 
quantity of HBeAg was shed from infected cells. Immunohistochemistry 
(IHC) also detects the presence of HBV in the given sample in the lab. 
Fig 16 : Hepatitis B Positive ImmunoHistoChemistry 
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        Screening tests for HBV infection 
Hepatitis is diagnosed by testing the haematological parameters, 
biochemical parameters, serological and coagulation parameters in the 
given sample.24, 57   
Serological parameters consists of detection of hepatitis B surface 
antigen, hepatitis B e antigen and/or antibody to HBsAg , antibody (IgM 
and IgG) to hepatitis B core antigen and antibody to HBeAg  
The infectious nature of the person is determined by Serum HBsAg 
as it is present in both acute and chronic infections.24, 52, 57 
Only in the presence of HBsAg, the antigens Pre-S1 and pre-S2 are 
seen even very early in the incubation period. The presence of HBeAg is 
associated with relatively high infectivity and severity of disease.24, 57 
Anti-HBc, the first antibody to appear when demonstrated in serum 
indicates current or past HBV infection. Presence of IgM anti-HBc in 
high titre denotes acute infection. IgM anti-HBc is usually replaced by 
IgG anti-HBc  within 6 months but it some cases of chronic hepatitis it is 
seen. Once the patient was infected with HBV, IgG anti-HBc  is detected 
in his serum for his entire life.24, 52, 57 
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There is a positive correlation between the appearance of Anti-HBe 
after anti-HBc in serum and decreased infectivity, and if it replaces 
HBeAg  from the circulation, it denotes that the disease is in stage of 
resolution.24, 52, 57 
Anti-HBs,  replaces its Ag and appears in the blood, during the 
resolution of disease and its presence which was observed in over 80% of 
patients indicate that the immunity was developed against  HBV 24, 52, 57 
Those with Acute viral hepatitis who maintain constant serum 
HBsAg or persistence beyond 8-10 weeks after resolution of symptoms 
are likely to become carriers and are also at risk of developing chronic 
liver disease.24 
The mutation which occurs in virus makes the antigen undetectable 
and diagnosis of hepatitis B difficult in a rare situation.    
The Principal screening test and conclusive proof for detecting 
current (acute or chronic) HBV infection is the identification of HBsAg 
which is the first immunological marker to appear in a patient’s serum 
and exist in high quantities in the blood.  
The qualitative detection of HBsAg in human serum or plasma by 
an enzyme-linked immunosorbent assay test (ELISA) is a powerful and 
common method adopted for screening and diagnosis of HBV. 
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The correlation between HBV DNA replication and HBV gene 
expression can be obtained by examining the pathological specimens for 
the presence of HBV-associated antigens or particles using 
Immunofluorescence studies, immunohistochemistry, in situ 
hybridization and thin-section electron microscopy.24 
Risk groups 
The people who are at risk of contracting HBV are mentioned below24, 57 
1. Children to children contact in day-care centre in endemic areas 
2. Household with the persons infected with virus 
3. The workers who engage themselves in health care and public 
safety 
4. Patients undergoing haemodialysis and employees working in such 
centres59, 76 
5. Sharing of unsterile needles for IV drug abuse, acupuncture and/or 
tattooing 59 
6. Sharing of unsterile equipment (medical or dental) 
7. Those who live in endemic areas77 
8.  Those who travel to endemic areas77 
9. People who engage themselves in active sex with male or female or  
multiple or infected persons 
10. Persons with sexually-transmitted disease 
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11. Infants of HBsAg-positive mothers 
12. Children of immigrants from high HBV prevalence areas 
13. Persons requiring repeated blood transfusions 
Inspite of screening procedures which are normally adopted prior 
to blood transfusion, the longer window period, mutant strains of HBV 
and low level of virus in the circulation and very high infectivity makes 
the recipients to acquire HBV through blood transfusion even in 
developed countries.    
Obvious risk factors which are easily identified are not found in all 
patients with acute hepatitis B58 
Treatment 
At present acute hepatitis B infection has no specific treatment 
modality. Treatment can only be given on symptomatic basis.24, 52 
Supportive care is the major treatment. Anti- Hepatitis B virus 
immunoglobulin should be given as soon as possible after the exposure of 
the certain patient at high risk. Immune globulin losses its effectiveness if 
it is given after twenty four hours of exposure to HBV. 
FDA gave approval for three drugs for treating hepatitis B.  
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 Interferon-alpha 2b which is protein in nature used as 
natural defenses against HBV infection.  
 The drug which inhibits HBV DNA polymerase (Hepsera) 
is a nucleotide analogue, which is used as a treatment 
modality in cases of adult survivors of hepatitis B infection 
which is chronic in nature.  
 Lamivudine also given for the patients with this infection, 
but the main problem in this drug is development of 
resistance. 
Even though the vaccination is highly effective in most of the 
patients, in practice it is very difficult to get the persons who are involved 
in the risk groups, because of this most of the persons who are exposed to 
the virus was not able to give the vaccination properly. In future, 
regulations should be developed for the proper immunization to the 
exposed individuals56, 58 
To check the efficacy of the given vaccine, all the individuals who 
are vaccinated should be tested for the formation of immunoglobulins 
against the given antigen, after a period of 30 to 60 days after the last 
vaccination. 
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Treatment regarding the chronic hepatitis B infection should be 
mainly focused on (i) To prevent the circulation of virus within the body 
by totally the eliminating the virus (ii) To arrest the further progression of 
the disease occurred on the liver due to the virus (iii) Patient should be 
improved clinically (iv) To prevent progression to the development of 
carcinoma by reducing the viral markers in the circulation. Symptoms 
developed in the patients mainly depend on the changes in the viral 
markers which are developed due to the viral infection.24, 52 
There are two classes of treatment for chronic hepatitis B: 
1. Antiviral: Aimed at suppressing or destroying HBV by 
interfering with viral replication.52 
2. Immune modulators: Aimed at helping the human immune 
system to mount a defence against the virus. 
Currently, chronic hepatitis B is treated with interferons24, 52, 57, 91.   
 A research is going on regarding the transfer of antibodies from the 
immune person to the person who is carrier of the infection, by bone 
marrow transplantation to totally eliminate the infection from the carrier. 
24, 71 
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STEPS TO MINIMIZE THE RISKS POSED BY THE INFECTED 
CADAVER 
The degree of risk involved for the microbiology and the 
biomedical lab are well established, but there is no proper literature 
regarding the risk involved in the postmortem examination room. As 
there was no standard safety measures specifically designed for autopsy 
room based on the risks to which the persons are exposed, the safety 
standards which are formulated for the various clinical and investigative 
laboratories can be followed in mortuaries78. 
Although much has been written on how to perform necropsies on 
infected cadavers safely, there are remarkably few studies from which 
one can draw evidence upon which to base a “safe” postmortem practice. 
The most recent guidelines on postmortem practice published by the 
Royal College of Pathologists (London, UK)79 recommend that 
mortuaries adopt health and safety protocols for the performance of 
postmortem examinations for all necropsies performed on cadavers 
known or suspected to be infected with a hazard group 3 pathogen.  
Detailed examples of such protocols are presented in these 
guidelines79. Such detail falls beyond the scope of this review but the 
basic principles are presented here. 
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(1) Immunization:  
The importance of immunizing the persons engaged in post 
mortem work is demonstrated by the comparison made between 
the study which was conducted among the UK health care workers 
in the period 1985-1988 which showed the presence of 16 cases of 
occupationally acquired hepatitis and the other study which 
showed the reduction in number of positive cases following the 
awareness and availability of the vaccine80. So it becomes 
mandatory to vaccinate all persons coming in contact with tissues 
and fluids of the dead, against tetanus81, poliomyelitis81, 
tuberculosis82, and hepatitis B83. 
(2) Pre-necropsy testing:  
This should be considered in cases where there is reason to 
suspect that the body may be infected with a previously undetected 
category 3 pathogen. If pre necropsy testing was positive, it 
becomes both the medical and social responsibility of the 
pathologist to make the information about the disease reach the 
relatives and sexual partners through the treating physician84, 85. 
(3) Clothing:  
Contrary to the use in surgery, protective clothing worn 
during autopsy helps to reduce the risk of transmission of infective 
pathogens from the cadaver to the health care workers.  The 
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currently recommended clothing for performing necropsies 
provides safety to the autopsy performers in all aspects. It includes 
a cap/hood, a visor, a face mask with micro filter, surgical shirt and 
trousers, waterproof boots with steel toecaps, a full length gown, a 
waterproof apron and at least one pair of gloves 40, 83, 84, 86, 87, 88, 89,. 
Some pathologists may form a waterproof seal90. It may be 
hazardous also by a reduction in field of vision and 
communication91. O’Briain92 observed the increased frequency of 
cuts when compared to needle stick injuries in autopsies. There is 
inverse correlation between the frequencies at which the injury 
occur while during autopsy and the experience of person 
performing the procedure.  
Mast et al demonstrated the 63 % reduction in transfer of 
blood through needle stick injury by sutures and 86% reduction in 
transfer of blood through needle stick injury by hollow needles 
which were significantly achieved by wearing surgical gloves93. 
Weston and Locker40 stated that 31.8 % of the glove 
punctures which occur during autopsy procedures were not noticed 
at the time of puncture by the technician wearing the gloves. 
Though some authors felt it was an unnecessary expense to wear 
double gloves, it should be noted that the perforation rate of inner 
glove is reduced by the habit of wearing double gloves. According 
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to few authors, the gloves should be changed frequently during the 
post mortem examination irrespective of whether it was damaged 
or not. As it was observed that multiple perforations seen in the 
base of ring finger where normally we wear ring, it was advised 
that the glove should be donned only after removing the ring in 
order to reduce the frequency of glove perforations94. The gauntlets 
made of metal mesh90, 95, 96 or Kevlar97 can be used on non-
dominant hand to provide additional protection against cuts but not 
against needle stick injuries. Though the usage of gauntlets had an 
added advantage it gives a cumbersome feel and the autopsy 
surgeon cant able to feel the texture and consistency of the organs 
as it acts as an interface between the hand and the organ and 
restrict the usage of hand to a maximum90, 95.  
Weston and Lober40et al. have documented that among the 
8% glove punctures that occur during the course of post mortem 
examination, about 33 % was not recognized at the time of 
puncture which makes the pre existing injuries in the hands of 
autopsy performers to come in contact with infectious pool of 
blood and body fluids for a longer period. Although gloves are 
impermeable to HIV and HBV infection, punctured gloves are not. 
The most important way of reducing the infection associated with 
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glove puncture is frequent change of gloves and hand washing 
throughout the procedure and at the end of procedure40 
(4) Reduce aerosol formation:  
This is essential for reducing the risk of acquiring airborne 
infections such as tuberculosis98 and enteric pathogens99and for 
necropsies on patients suspected of having HIV or TSE. It should 
be realized that most airborne bacteria in mortuaries are derived 
from the skin of the staff present in the mortuary99, 100. The aerosol 
transmission and odour can be reduced by the use of down draught 
ventilation tables18, 99, 100. The risk of aerosols is high with use of 
power saws99. The intestine should be opened under water to reduce 
the risk of aerosol81, 90, 95, 96. As splashing of water and body fluids 
increase the formation of aerosol, avoid using water sprays at high 
pressure81, 99. The clean plastic bags can be placed over head at the 
time of removing the brain to reduce spread of aerosols101. The 
advantage in eviscerating the infected body, organ by organ when 
compared to Letulle technique of en bloc removal was observed by 
some authors91. Instead of plastic bags, specific tents have been 
designed to reduce the aerosol by covering the head and neck of 
cadaver101. 
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(5) Equipment:  
Those workers who are at frequent exposure to sharp objects 
(Needles or Instruments) and blood are at increased risk of 
acquiring hepatitis B virus infection102. Only minimum equipment 
that was kept in a clear view should be used. Avoid instruments 
with pointed ends88,91. Instruments (especially sharps) should be 
transferred from one’s hand to other through a vehicle, commonly 
used is kidney tray90. Use disposable instruments, whenever 
possible, in high risk cases. Non-disposable instruments needs to 
be disinfected for longer periods90.  
(6) Circulators: 
All high risk autopsy cases need not performed in a 
specialist mortuary, but make sure only minimum persons are 
present during the procedure91, 103. Therefore, in practice, the 
pathologist, anatomical pathology technician and circulator will be 
in the autopsy rooms, 90, 104   first two persons will be in contact 
with the cadaver and collect the samples, third one will help in 
other clerical work associated with such specimens. The circulator 
constantly monitors the other two persons involved in autopsy and 
ensures that the safety is maintained inside the mortuary as per the 
health and safety guidelines104. 
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(7) Safe sharps practice:  
As the sharp ends of the instruments used by the autopsy 
performers and the sharp ends of the fractured fragments of bone 
and unanticipated sharp objects that may present within cadaver 
may come in contact with the personnel any time during the 
procedure, safety should be look into by all means. At any cost 
avoid dissecting the cadaver blindly. The safety acquired through 
the practice of evisceration in post mortem examination was 
evaluated by only one study.  
Walker etal found that increased risk of injuries occurring 
by sharp edge of ribs which was produced by using rib shears is 
better avoided by using an electric saw, but it has an disadvantage 
of increasing the risk of aerosol and vibration induced white 
fingers (when used for long time) in the persons handling them105, 
106. In considering the safety of the persons handling the dead 
bodies, some authors recommend the use of staples or tissue 
adhesives to close the post mortem incision wound and reconstruct 
the body instead of suturing, as the gauntlets we use also won’t 
protect us from suture needles. Some authors even say to leave the 
body as such in a leak proof body bag and seal it84, 91.  Regarding 
the best way of handling the infected body, till now no proper 
studies or no standard guidelines were available. 
72 
 
Herbst et al, 2009 stated that the Universal precautions for 
blood and body fluids and enteric precautions should be followed42. 
Other personal protective equipment like eye wear, gowns 
and masks are only required when large splashes of blood are 
anticipated. 
Curti and Biran, 2001 stated that the hands should be 
washed after handling the cadaver and before eating and all 
equipment washed with disinfectant42. 
Rischetelli et al, 2001 and De ville,1980 in his study stated 
that the body bags which are used, can also reduce the infection 
and are useful for transportation of cadavers which are badly 
damaged. But the body bag reduces the rate of cooling and increase 
rate of decomposition especially in hot climate42. 
PROPHYLAXIS 
Hepatitis B vaccination prevents infection and is 70-80% effective 
within a week of exposure. Therefore while dealing with cadavers, 
covering of cuts or lesions with water proof dressings, careful cleansing 
of any injuries sustained during embalming, particularly use of 
appropriate protective clothing will greatly reduce the risk of acquired 
infection34. 
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IMMUNISATION SCHEDULE 
 1st dose at elected date 
 2nd dose should be given 4 to 10 weeks after the 1st dose 
 3rd dose should be given 1 to 5 months after the 2nd dose 
Booster dose should be given particularly for all people at risk, 
when the anti-HBs antibody titre falls below 10 IU/L. After the 0, 1, 2 
months of primary immunization schedule a booster dose is 
recommended 12 months after the first dose. After 8 years the next 
booster may be required. After the 0, 1, 6 months primary immunization 
schedule a booster dose may be required after 5 years after the primary 
course. 
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METHODOLOGY (MATERIALS & METHODS) 
The samples were tested blindly that the identity of the individual 
was unknown. The samples were collected via cardiac chamber at the 
time of autopsy.                           
Reagents And Materials Provided with Human HBsAg ELISA Kit:  
Microwell Plate:  
The blank microwell strips fixed on white strip holder is sealed in 
aluminum pouch with desiccant. Each well contains monoclonal 
antibodies reactive to HBsAg (anti-HBs). It can be broken and use 
separately if the sample volume is small. The unused wells or strips is 
placed back in the bag provided and maintained a 2-8°C. 
Negative Control:  
Protein-stabilized buffer yellowish in color and tested non-reactive 
for HBsAg. It is identified by green screw cap.  
Positive Control:  
HBsAg diluted in protein-stabilized buffer which is red in color. It 
is identified by red screw cap  
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HRP-Conjugate:  
Horseradish peroxidase - conjugated anti-HBs antibodies which is 
also a red-colored liquid. To distinguish from positive conjugate which is 
also of same color, it is kept in a white vial with red screw cap 
Specimen Diluents:  
It is Serum base, casein and sucrose solution in green color placed 
in a vial with blue screw cap. 
Wash Buffer:  
Colorless liquid filled in a clear bottle with white screw cap. PH 
7.4, 20x PBS. The concentrate must be diluted 1 to 20 with distilled/ 
deionized water before use. Once diluted, stable for one week at room 
temperature, or for two weeks when stored at 2-8°C.  
Chromogen Solution A:  
Urea peroxide solution which is a colorless liquid. It is kept in a 
white vial with green screw cap.  
Chromogen Solution B:  
TMB solution (Tetramethyl benzidine dissolved in citric acid) a 
colorless liquid. It is kept in a black vial with black screw cap.  
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Stop Solution:  
Diluted sulfuric acid solution (0.5M H2SO4) a colorless liquid in a 
white vial with white screw cap.  
Note:   
Microwell Plate, Negative Control, Positive Control and HRP- 
Conjugate, Chromogen Solution A, Chromogen Solution B, Stop 
solution will be stable only for one month after it was opened only 
when the optimal temperature is maintained. All are ready to use as 
supplied 
Principle of the Test:  
Human HBsAg ELISA Kit uses antibody "sandwich" ELISA method 
for detection of HBsAg, in which, polystyrene micro well strips are pre-
coated with monoclonal antibodies specific to HBsAg.  
a) Add Patient's serum or plasma sample to the microwells  
b) Polystyrene micro well strips are pre-coated with monoclonal 
antibodies specific to HBsAg  
c) During incubation, if HBsAg is present in the sample, the specific 
Ag Ab complex formed is captured on the solid phase.  
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d) Then the second antibody conjugated the enzyme horseradish 
peroxidase (the HRP-Conjugate) directed against a different 
epitope of HBsAg is added into the wells.  
e) During the second incubation step, these HRP-conjugated 
antibodies will be bound to any anti-HBs-HBsAg complexes 
previously formed during the first incubation, and the unbound 
HRP-conjugate is then removed by washing.  
f) Chromogen solutions A and B are added to the wells.  
g) In presence of the antibody-antigen-antibody (HRP) "sandwich" 
immunocomplex, the colorless chromogens are hydrolyzed by the 
bound HRP-conjugate to a blue-colored product.  
h) The blue color turns yellow after stopping the reaction with 
sulfuric acid. 
The amount of color intensity can be measured by determining 
absorbance using 450nm as reading wavelength with 620-690 nm 
reference wavelength which is proportional to the amount of antigen 
captured in the wells, and to its amount in the sample respectively. 
Wells containing samples negative for HBsAg remain colorless. 
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Fig 17: Diagram of Generic 'Antigen Sandwich' Elisa for Completed 
Generic Elisa Assay 
 
 
A – Blank                                                                 G - Sample 1 Positive 
 
 
B C D - Negative controls                                        H - Sample 2 Negative 
E F - Positive controls 
 
 
 
Table 4 : Interpretation of the HBV serological markers 
 
Tests Results Interpretation 
HBsAg 
 
anti-HBcAg 
 
anti-HbsAg 
Negative 
 
Negative 
 
Negative 
 
1. No HBVexposure 
 
2. Not vaccinated 
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HBsAg 
 
anti-HBcAg 
 
anti-HbsAg 
Negative 
 
Positive 
 
Positive 
 
1. Infected with HBV 
 
2. And Immune 
HBsAg 
 
anti-HBcAg 
 
anti-HbsAg 
Negative 
 
Negative 
 
Positive 
 
1. Vaccinated and Immune 
 
2. Not infected 
HBsAg 
 
anti-HBcAg 
 
anti-HBcAg IgM 
 
anti-HbsAg 
Positive 
 
Positive 
 
Positive 
 
Negative 
 
 
 
       Acute HBV infection 
HBsAg 
 
anti-HBcAg 
 
anti-HBcAg IgM 
 
anti-HbsAg 
Positive 
 
Positive 
 
Negative 
 
Negative 
 
 
 
         Chronic infection 
HBsAg 
 
anti-HBcAg 
 
anti-HBsAg 
Negative 
 
Positive 
 
Negative 
1. Recovery from Acute 
HBV infection 
2. HBV carrier 
3. Window period 
4. False positive to anti- 
HBcAg 
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Subject Selection:  
Study would be conducted on those cases, coming for Medico 
Legal autopsy to the Institute of Forensic Medicine, Madras Medical 
College, Chennai - 600003. The identity of the individual should not be 
disclosed in any part of the study.  
Inclusion Criteria:  
All dead bodies subjected for autopsy 
Exclusion Criteria:  
All decomposed dead bodies subjected for autopsy  
LIMITATIONS OF THE TEST:  
1. Only un-pooled human serum or plasma can be used  
2. HBV infection cannot be excluded without considering the other 
evidences for the same by taking only the negative HBsAg 
obtained 
PERFORMANCE CHARACTERISTICS 
(i) Diagnostic specificity: 99.58% 
(ii) Diagnostic sensitivity: 100% 
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ANALYSIS AND RESULTS 
Out of the 515 samples tested, Males occupy predominant number 
of cases, accounts for about 86.6% of study samples, whereas female 
constitute only 13.2% of the study sample.  
Of the 515 samples tested, HbsAg were detected in 18 samples 
(3.5%) using ELISA kit. All the positive cases were not previously 
known to have HBV-infection. Data such as demographics, cause of 
death, brought dead or treated, post mortem interval and positivity for 
HbsAg are recorded.  
Out of the 18 positive samples, 13 were male and 4 were female 
and 1 transgender.  
Table 5: Sex distribution among the study sample 
Sex 
No. of 
Cases 
 
Percentage 
of Cases 
 
No. of 
positive 
cases 
Percentage 
of 
positive 
cases 
Male 446 86.6% 13 2.9% 
 
Female 68 13.2% 4 5.9% 
Transgender 1 0.2% 1 100% 
Total 515  18 3.5% 
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Among 515 cases analyzed, predominant numbers of cases are 
male patients (86.6%). In this study, out of the 18 positive cases, thirteen 
cases were positive among the males (72.2%) with 2.9 % of overall 
positive cases and four cases were positive among the females (22.22 %) 
with 5.9 % of overall positive cases, one case was found in transgender 
(5.5 %) with 0.2 % of overall positive cases. In this study the prevalence 
of HBV is 100 % in Transgender as only one case was tested and it came 
as positive which is followed by male population.  
Fig 18: Sex distributions among the study sample 
 
Fig 19 : Positivity among both the sexes 
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Table 6: Age distribution among the study sample 
S.no 
Age 
distribution 
No. of 
sample 
Percentage 
of samples 
No. of 
positive 
cases 
Percentage 
of positive 
cases 
1.  
0 - 10 years 7 1.36% 0 0% 
2.  
11 - 20 years 30 5.82% 0 0% 
3.  
21 - 30 years 121 23.5% 6 4.95% 
4.  
31 - 40 years 87 16.9% 4 4.59% 
5.  
41- 50 years 121 23.5% 5 4.13% 
6.  
51- 60 years 87 16.9% 3  
3.45% 
7.  
61- 70 years 45 8.74% 0  
0% 
8.  
71- 80 years 15 2.91% 0 0% 
9.  
81- 90 years 2 0.4% 0 0% 
10. 
Total 515  18  
 
Among 515 cases analyzed, predominant number of cases falls 
under age group between 21 to 30 and 41 to 50, followed by age group 
between 31to 40 and 51 to 60. In this study, Out of the 18 cases, six cases 
were positive in the age group 21-30, five cases were positive in the age 
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group 41-50, four cases were positive in the age group 31-40 and three 
cases were positive in the age group 51-30 indicating that highest 
seroprevalence was in the age group 21-30.   
Fig 20: Age distribution among the study sample  
 
Fig 21: Positivity percentage among the age distribution in study 
sample  
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Table 7 : Distribution of manner of death among the sample collected 
and positive cases of the study sample 
S.No Cause of death 
No. 
of 
cases 
Percentage 
of cases 
No. of 
positive 
cases 
Percentage 
of positive 
cases 
1.  
Natural cause 53 10.3% 4 7.56% 
2.  
Road traffic 
accident 
265  
51.46% 
3 1.13% 
3.  
Train traffic 
accident 
34  
6.6% 
2 5.88% 
4.  
Hanging 19  
3.69% 
3 15.79% 
5.  
Fall 59  
11.46% 
1 1.7% 
6.  
Murder 17  
3.3% 
3 5.13% 
7.  
Poisoning 39  
7.57% 
2 5.13% 
8.  
Other causes* 29  
5.63% 
0 0% 
9.  
Total 515  18  
* (Snake Bite – 10, Electrocution – 8, Suspicious Death - 3, Scorpion Bite 
- 1, Industrial accident - 1, Drowning - 3, Accident - 2, Burns - 1) 
Among 515 cases analyzed, predominant number of cases falls 
under the category of Road Traffic Accidents (51.46%), followed by Fall 
from height (11.46%), Natural cause (10.3%), Poisoning (7057%) and 
others. In this study, Out of the 18 positive cases, four cases were positive 
in the Natural cause, Three cases were positive in the RTA, Hanging and 
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Murder cases, two cases were positive in TTA and Poisoning and one 
case was positive in the Fall from height. Even though Road traffic 
accidents constitute the majority of samples collected (51.46%) and 
Natural cause (with 7.56 % of seroprevalence) constitutes 22.23 % of 
overall positive samples, highest seroprevalence was noted in case of 
Hanging with 15.79% (Three cases were positive out of nineteen cases) 
with 16.67% of overall positive samples (Three out of eighteen cases).  
This shows that HBV screening is of great importance among the 
cases we receive for autopsy irrespective of manner of death. Hanging 
and natural cause in our study showed a relatively higher prevalence of 
HBV infections compared with other manners of deaths. 
Fig 22: Distribution of manner of death among the study sample 
          
10%
51%7%
4%
11%
3% 8%
6%
Natural cause
Road traffic accident
Train traffic accident
Hanging
Fall
Murder
Poisoning
Other causes*
89 
 
Fig 23: Distribution of percentage of positive cases of the study 
sample among the manner of death 
 
Table 8: Distribution of Brought dead cases among the study sample 
S.No Cases No of 
Cases 
Percentage 
of cases 
No of 
Positive 
cases 
Percentage 
of positive 
cases 
1.  Brought Dead 91 17.67% 12 13.2% 
2.  Hospital 
Treated 
424 82.33% 6 1.42% 
 Total 515  18  
 
Among 515 cases analyzed, predominant number of cases falls 
under the category of Hospital treated patients (82.33%). In this study, 
Out of the 18 positive cases, twelve cases were positive among the 
brought dead category (13.2%) with 66.67 % of overall positive cases and 
six cases were positive among the hospital treated category with 33.33% 
of overall positive cases.  
18% 3%
14%
37%
4%
12%
12%
0%
Natural cause Road traffic accident Train traffic accident
Hanging Fall Murder
Poisoning Other causes*
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This shows that HBV screening is of great importance among the 
cases we receive for autopsy as their HBV status was not known (66.67% 
were brought dead with no details regarding history of exposure or blood 
transfusion or HBV/HIV status) 
Fig 24: Distribution of brought dead and treated case among study 
sample  
 
Fig 25: Distribution of Positive case among the brought dead and 
treated case in the study sample  
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Table 9: Distribution of Post mortem interval among the study 
sample 
S.No Post mortem        
interval 
No. of 
Samples 
Percentage 
of  
samples 
No. of 
Positive 
cases 
Percentage 
of positive 
cases 
1.  < 6 Hours 26 5.04% 1 3.85% 
2.  6 – 12 Hours 101 19.6% 2 2% 
3.  12– 24 Hours 263 51.1% 13 4.94% 
4.  24– 36 Hours 101 19.6% 2 2% 
5.  >36 Hours 24 4.7% 0 0% 
 Total 515  18  
 
Among 515 samples analyzed, predominant number of samples 
was collected between 12 to 24 hours (51.1%), followed 6 to 12 hours 
(19.6%) and 24 to 36 hours (19.6%). In this study, out of the 18 positive 
cases, thirteen cases were positive among the samples collected 12 to 24 
hours after death (positive percentage of 4.94%) with 72.22 % of overall 
positive cases.  
The samples collected upto 36 hrs after death showed positive 
results for HbsAg. This shows that HBV screening is of great importance 
among the cases we receive for autopsy as HbsAg was detected even in 
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the post mortem blood samples and hence HBV can be transmitted from 
cadaver to health care workers 
Fig 26: Distribution of Post mortem interval among the study sample  
 
Fig 27: Distribution of Positive percentage among Post mortem 
interval in the study sample  
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Table 10: Distribution of nature of occupation among the study 
sample 
S.No Occupation No. of 
Cases 
Percentage 
of cases 
No. of 
Positive 
cases 
Percentage 
of positive 
cases 
1.  Coolie  248 48.12% 6 2.42% 
2.  Private  72 14% 1 1.4% 
3.  Driver  38 7.4% 4 10.53% 
4.  House wife  27 5.24% 1 3.7% 
5.  Security   7 1.4% 1 14.3% 
6.  Merchant  5 1% 1 20% 
7.  Cleaner  2 0.4%  1 50% 
8.  Fish man  3 0.6% 1 33.3% 
9.  Sex worker  1 0.2% 1 100% 
10. NK  5 1% 1 20% 
11. Other 
occupation* 
107 20.78% 0  
 Total 515  18  
* (Student – 24, Farmer – 19, Painter -12, Govt – 11, Mason – 7, Tailor – 
7, Business – 4, Carpenter- 4, Retd – 4, Kid – 3, Electrician – 2, 
Mechanic – 2, Cashier – 1, Cine field – 1, Cook – 1, Gold smith – 1, 
Butcher – 1, Lawyer – 1, Broker – 1,Plumber – 1,) 
 
Among 515 cases analyzed, predominant number of cases falls 
under the category of Coolie (48.12%) followed by Private Employee 
(14%) and Driver (7.4%). In this study, Out of the 18 positive cases, Six 
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cases were positive in Coolie, Four cases were positive in Drivers and 
other eight positive in Private employee, House wife, Merchant, Security, 
Cleaner, Sex Worker, fish man and Not Known category. Even though 
Coolie constitute the majority of samples collected (48.12%) with 2.42 % 
positive percentage and constitutes 33.3 % of overall positive samples, 
highest seroprevalence was noted in case of Sex worker with 100% (One 
case tested which was found to be positive) with 5.56% of overall 
positive samples (One out of eighteen cases).  
This shows that HBV screening is of great importance among the 
Coolie and commercial sex workers which showed a relatively higher 
prevalence of HBV infections compared with other occupations 
Fig 28: Distribution of Occupation among the study sample  
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Fig 29: Distribution of Positive percentage among the various 
occupational groups in the study sample  
 
Table 11: Distribution of marital status among the study sample 
S.No Marital 
Status 
No. of 
Cases 
Percentage 
of cases 
No. of 
Positive 
Cases 
Percentage 
of positive 
cases 
1.  Married 402 78.1% 13 3.23% 
2.  Single 108 21% 4 3.73% 
3.  Not Known 5 1% 1 20% 
 Total 515  18  
 
Among 515 cases analyzed, predominant number of cases falls 
under the Married category (78.1%) followed Single (21%). In this study, 
Out of the 18 positive cases, thirteen cases were positive in married 
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population, four cases were positive in Singles. Even though Married 
population constitute the majority of samples collected (78.1%) with 
72.33 % of overall positive samples, Both Married and Single constitutes 
seroprevalence of about 3% positive percentage with unknown category 
having highest seroprevalence of 20% (One in five cases positive) with 
5.56% of overall positive samples (One out of eighteen cases).  
This shows that HBV screening is of great importance in the 
Spouse and children when the deceased was found to be positive in 
autopsy samples. Dead bodies brought as unknown without no relatives 
showed a relatively higher prevalence of HBV infections compared with 
other category. Hence unless clearly indicated, unknown bodies should 
not be subjected for autopsy as a routine procedure. 
Fig 30: Distribution of Marital status among the study sample  
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Fig 31 : Distribution of positive percentage among the marital status 
in the study sample  
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DISCUSSION 
Hepatitis B virus had an increased morbidity and mortality among 
the mortuary workers due to its high frequency among the deceased and 
longevity of the virus14. Amongst all the parenteral viruses, Hepatitis B 
virus has the highest transmissibility rate with a rate of about 100 times 
greater than HIV  
Carolin et al suggested that post-mortem blood samples should be 
collected within 24 hours. Challine et al. (2006) recommended 12 h 
maximum time for drawing post-mortem blood samples. In my study 
HbsAg was detected in the post mortem blood samples upto 36 hours. 
In 2012 in India about 119,000 cases of all cause of viral hepatitis 
were reported. The estimated burden of chronic HBV infection in the 
South-East Asia region was 100 million. After HEV, HBV is the second 
most common cause of acute viral hepatitis in India with over 40 million 
HBV carriers. India is considered to have an intermediate level of HBV 
with 3.7% point prevalence. 
In India, every year one million populations are at risk and about 
100,000 die from HBV infection. Though HDV infection is not very 
common in India it is observed in 10% to 20% of HBV positive patients. 
Genotypes A and D of HBV, and genotypes 1 and 3 of HCV are 
more prevalent in India. 
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In India epidemics due to the practice of unsafe injection among 
injecting drug users and healthcare workers caring the infected people 
46% of hepatitis B carriage and 38% of HCV infection were documented. 
In India, HBV infection was transmitted perinatally in about 10% 
of cases when the mother is only hepatitis B surface antigen (HBsAg) 
positive but when the mother is positive for both HBsAg and hepatitis  B 
e-antigen (HBeAg) the transmission rate increases to 90%  
Universal immunization against hepatitis B was introduced in India 
in 10 states in the year 2002 and in 2011 countrywide. A pentavalent 
vaccine which was introduced recently in some states gives protection 
against HBV also. 
A simple, reliable, and rapid test to detect HBV infection can be 
useful in the mortuary because it is not possible always to get the 
complete and correct information about all of the risk factors before 
commencing the postmortem, because of the social and cultural 
restrictions. Therefore the lack of a known history of such a risk factor 
does not equate with the nonexistence of such risk factor. Hence testing 
for HBV in medico-legal autopsies will identify carriers in whom BIV 
status was not previously known. 
Li et al30 reported 23% prevalence of hepatitis B in forensic 
autopsy performers 
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 Plessis et al41 reported 8% prevalence of hepatitis B in forensic 
autopsy performers  
In this study, the eighteen positive cases out of 515 cases were not 
known to have HBV which means they are clinically undetected for 
HBsAg. This indicates that that people at high risk are clustered in the 
medico-legal autopsy series. 
There are many studies that have estimated the survival of the 
HBV postmortem.  HBV survive outside the human body for upto 7 – 10 
days and can withstand drying for atleast a week. When stored at 30-32 
degree Celsius, HBV retains its infectivity for atleast 6 months and when 
frozen at -15 degree Celsius, its infectivity will be retained for upto 15 
years. During the early phase of infection, the viral load in blood and 
other body fluids may be very high. This suggests the need for efficient 
protection of autopsy personnel’s during all autopsies. 
The testing of postmortem sera for HbsAg will be a most reliable 
measure of antemortem HBV infection. HbsAg and anti -HbsAg have 
been shown to remain detectable in postmortem serum stored for 
relatively long periods of time. Furthermore, it has been demonstrated 
that by assessing the post mortem changes in the serological parameters 
Kitchen and Newham established the post mortem stability of serological 
markers upto 24 hours after death. East lund and Schuller demonstrated 
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that the post mortem stability of the stability of the antibodies was similar 
when compared to the ante mortem screening done in live donors.  
In general, proteins such as the globulins that comprise antibodies 
may not be affected by postmortem decomposition, hemolysis, or 
bacterial contamination23, 30. In this study, it was estimated that the 
postmortem interval was ranging from 6 hours to 36 hours for detection 
of HbSAb. 
Postmortem viral level is influenced by several factors like viral 
burden of death, viral strain, pre-mortem antiviral therapy and 
temperature maintained in the mortuary. HBV is transmitted from person 
to person when they come in contact through blood, vaginal fluid, semen, 
breast milk, CSF, amniotic, pericardial and synovial fluids. Others such 
as saliva, tears, urine unless they found to be contaminated with blood in 
adequate volume are not implicated in the transmission of HBV. 
British clinical laboratories conducted a study in 1970 - 1989 and 
established that the rate of infections acquired through handling of 
laboratory equipments and specimens was highest in mortuary workers. 
Weston and Lober have recognized that about 8% surgical gloves get 
punctured during post-mortem and nearly one third of that was 
undetected by the pathologist, thus causing the infectious blood to be 
bathed in any preexisting hand injuries for a prolonged period of time40. 
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In the present study, the samples were tested blindly, that the 
identity of the individual was unknown. This study includes all types of 
forensic autopsy cases representing the general population. Samples of 
blood were collected from 515 autopsy cases at Rajiv Gandhi 
Government General Hospital. All the samples were tested for HbSAg 
using standard Human HBsAg ELISA kits which has a sensitivity of 
99.58% and specificity of 100%. 
Out of 515 cases, there are eighteen positive cases and thirteen 
positive cases were male, four positive cases were female and one case 
was transgender. The presence of 18 positive cases among 515 cases, 
though statistically insignificant is higher than many other voluntary 
screening programs (The seroprevalence of HIV, HBV, HCV and syphilis 
was found to be 0.154%, 0.887%, 0.101%and 0.22% respectively in 
voluntary blood donors ( A study on Sero prevalence of HBV, HCV, 
HIV and syphilis among blood donors at a tertiary Care Teaching 
Hospital in Western India). In many voluntary screening programs there 
are people who abstain from testing, which does not affect in this study. 
Thus, screening in medico legal autopsy is a sensitive indicator 
epidemiologically. 
Many studies conducted for detecting the HbsAg in the autopsy 
population were classified the deceased as “known risk” and “no known 
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risk” groups based on the history such as infection, drug addiction, and 
sexual contact but that was not reliable and leads to misclassification. So, 
in this study such data about the risk factors were not collected. 
           There are two opinions concerning HBV in autopsies. One school 
of thought maintains that all autopsies should be carried with universal 
precaution which is almost impracticable in a developing country. The 
second thought recommends pre autopsy testing for HBV by rapid test 
kits in the mortuary by taking blood samples from the dead body. If the 
result is positive, then universal precautions to be observed while 
conducting autopsies. 
LIMITATION OF THE STUDY: The obstacles for postmortem testing 
of blood and body fluids include hemolysis, autolysis, bacterial 
contamination, and loss from decomposition. These obstacles are 
enhanced by prolonged postmortem intervals. However, 
immunoglobulins, are considered less likely to be affected by 
decomposition, hemolysis and bacterial contamination. 
This screening test for the HbsAg may not be sensitive if the 
person was in the window period 
 
 
105 
 
 
 
 
 
 
 
CONCLUSION 
 
 
 
 
 
 
 
106 
 
CONCLUSION 
The health care professionals who are involved in the postmortem 
work are exposed to a greater risk of occupational health hazard due to 
higher prevalence of various infectious diseases among the general 
population. It is wise to practice the Universal Precautions in almost all 
dead bodies considering it as infectious as it becomes practically 
impossible to know the medical status of each and every body subjected 
for autopsy.  
The autopsy based occupational health hazards can be reduced by 
focusing on improvement in assessment, training, education, personal 
protection, autopsy techniques and autopsy room.  
Health care professionals involved in postmortem practice should 
be aware of the hazards and risks associated with the cadaver, instruments 
they handle and the atmosphere in which they work and take necessary 
steps to minimize the risks. Careful practice avoids many accidents in 
mortuary. 
The present study concludes that testing of HBV in medico legal 
autopsies is a convenient and effective method in monitoring the 
surveillance of HBV-infection in the general population and it can be 
used for epidemiological studies. It could be used along with unlinked 
anonymous tests from hospital and other similar patient materials. 
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Testing for HBV may also be desired for safety reasons in 
mortuaries81. In screening postmortem blood for HbSAg, the present 
study represents that HbSAg ELISA kit is simple, rapid, no special 
equipment are required, even whole blood can be used and has very high 
sensitivity of 99.58% and specificity of 100% and  
Out of 515 subjects in this study group, 18 cases were positive for 
HBV and all were previously unknown seropositive cases. Though the 
rate of infection appears to be less than 1%, even with a needle stick, it is 
not practical or economical to take universal precautions with every 
autopsy. It would, therefore, be advantageous to know a deceased HBV 
serological status prior to autopsy. Screening may be worthwhile in cases 
at high risk of HBV infection where the HBV status is not known at the 
time of postmortem. 
UNIVERSAL PRECAUTIONS WHICH SHOULD BE FOLLOWED 
DURING ROUTINE AUTOPSY PROCEDURES 
Universal precautions should be followed for blood, vaginal 
secretions and semen as well as to peritoneal, pericardial cerebrospinal, 
synovial, pleura fluids and it is believed that tears, nasal secretions, 
sweat, sputum, urine, faeces and vomitus and amniotic fluids are not 
infectious unless they contain visible blood. 
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Only experts and health care professionals those who are skilled in 
handling the infected materials are allowed to enter in to the postmortem 
examination room. Only those experienced professionals should conduct 
the autopsy examination as it is proved through many studies that the risk 
of accidental infection was more common, when the post mortem 
procedure was done by an inexperienced person.  Studies reported that 
the occurrence of lacerated wound in the body of the performer in 1 in 
every 11 autopsies conducted by inexperienced persons. Postmortem 
examination should not involve those persons with breach in the skin or 
mucosa or body immunity. 
The internal atmosphere of the postmortem examination room 
should be in such a way with sufficient space to avoid overcrowding and 
provide proper ventilation. Protective measures such as wearing gloves, 
headwear, masks, eyewear, shoes and full-covered gown should be given 
to and used by the mortuary staff while they are doing the postmortem 
work. Gloves should be checked often for cuts and puncture to prevent 
them from getting contaminated and infected by infectious leakage. 
Wearing double gloves during the procedure will help us to minimize the 
risk of cutaneous exposure to the infected blood  
It should become a routine practice of washing your hands, after 
handling contaminated and infected blood and body fluids and also after 
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the removal of gloves and check for the perforation in the removed 
gloves. Gloves should be washed as routine procedure after autopsy to 
remove the contaminated blood and/or other body fluids, as there is high 
chance of transferring the contamination to all the surfaces coming in 
contact with the performers. Sharp instruments should not transferred 
directly from one’s hand to other's hand while doing the postmortem 
work to other, without a vehicle in between All Disposable sharp 
materials should be carefully placed in puncture resistant containers and 
later disposed in a very safe manner. 
As prevention is always better than cure, the following preventive 
measures such as screening and immunization of the persons who are 
considered as high-risk groups based on the history of exposure to 
infection and infected personnel, risk involved in their routine day to day 
practices and risk involved in the occupation in which they are engaged. 
Recommended safety measures should be followed in the area of Child 
Birth, Blood Transfusion, Injections, Sex and in all places wherever we 
comes in contact with blood and body fluids. 
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STUDY OF SEROPREVALENCE OF HEPATITIS B VIRUS IN         
MEDICO LEGAL AUTOPSIES 
Proforma: 
Postmortem No:                      Date:                   Age:            Sex: 
History of the case and Manner of Death: 
Marital status: 
Occupation: 
Brought Dead or Hospital treated: 
Date and Time of Death: 
Date and Time of Postmortem examination: 
Known case of Hepatitis B: yes/No 
Samples Collected:                                                   
1) Blood from left ventricle: Yes/No 
Investigation: To detect the presence of HBsAg in the collected sample 
using Human HBsAg ELISA Kit. 
 
  
 
 
 
 
 
 
          MASTER CHART 
Serial 
No 
P.M.No  Age  Sex Marital 
Status  
Manner of 
Death 
Occupation Brought 
Dead or  
Treated 
Date & 
Time of 
Death 
Date and 
Time of 
Autopsy 
                         Time since death in Hours 
 
 
    
Known 
HBV 
status 
Sample 
Result - 
HBsAg  
Positive 
          < 6 6 – 12 12 – 24 24 - 36 >36   
1.  867/14 60 M Married Hanging Farmer Treated 14.05.14  
07.25 A.M 
14.05.14  
01.00.P.M 
Yes     No No 
2.  868/14 44 M Married RTA Farmer Brought 
dead 
13.05.14 
12.30P.M. 
14.05.14 
01.30 P.M 
   Yes  No No 
3.  869/14 54 M Married RTA Coolie Treated 13.05.14 
10.15 A.M 
14.05.14 
02.00P.M. 
   Yes  No No 
4.  870/14 50 M Married RTA Coolie Treated 12.05.14 
04.45 P.M 
14.05.14 
02.00 P.M 
    Yes No No 
5.  871/14 58 M Married Fall Coolie Treated 14.05.14 
04.00 A.M 
14.05.14 
02.00 P.M 
 Yes    No No 
6.  872/14 20 M Married Hanging Coolie Brought 
dead 
14.05.14 
1.20 A.M 
15.05.14 
12.10 P.M 
   Yes  No No 
7.  873/14 30 F Married Natural House wife Brought 
dead 
14.05.14 
02.00 A.M 
15.05.14 
01.00 P.M 
   Yes  No No 
8.  874/14 27 M Married RTA Coolie Treated 15.05.14 
05.30 A.M 
15.05.14 
02.00 P.M 
 Yes    No No 
9.  876/14 48 M Married Fall Private Treated 15.05.14 
06.20 A.M 
15.05.14 
04.00 P.M 
 Yes    No No 
10.  877/14 25 M Single TTA Cook Brought 
dead 
15.05.14 
07.40 A.M 
15.05.14 
05.00 P.M 
 Yes    No No 
11.  878/14 23 M Single RTA Driver Treated 15.05.14 
01.00 P.M 
16.05.14 
11.00 A.M 
  Yes   No Yes 
12.  879/14 28 M Married RTA Driver Treated 16.05.14 
04.50 A.M 
16.05.14 
11.55 A.M 
 Yes    No No 
13.  881/14 65 M Married RTA Coolie Treated 15.05.14 
06.15 A.M 
16.05.14 
01.15 P.M 
   Yes  No No 
14.  882/14 24 M Single RTA Coolie Treated 15.05.14 
01.30 P.M 
16.05.14 
04.00 P.M 
   Yes  No No 
15.  883/14 32 M Married Fall Coolie Treated 16.05.14 
07.35 A.M 
17.05.14 
11.00 A.M 
   Yes  No No 
16.  885/14 49 M Married RTA Mason Brought 16.05.14 17.05.14   Yes   No No 
dead 02.30 P.M 12.40 P.M 
17.  886/14 21 M Single RTA Private Treated 17.05.14 
03.30 P.M 
18.05.14 
12.15 P.M 
  Yes   No No 
18.  887/14 29 M Married RTA Coolie Brought 
dead 
17.05.14 
06.30 P.M 
18.05.14 
01.00 P.M 
  Yes   No No 
19.  888/14 90 M Married Hanging Coolie Treated 18.05.14 
12.30 A.M 
18.05.14 
01.15 P.M 
  Yes   No No 
20.  889/14 29 M Married Snake Bite Coolie Treated 18.05.14 
07.50 A.M 
19.05.14 
10.15 A.M 
   Yes  No No 
21.  890/14 27 M Married RTA Coolie Treated 18.05.14 
04.02 P.M 
19.05.14 
12.40 P.M 
  Yes   No No 
22.  891/14 40 M Married RTA Coolie Treated 18.05.14 
06.45 P.M 
19.05.14 
01.30 P.M 
  Yes   No No 
23.  892/14 58 F Married RTA Coolie Brought 
dead 
18.05.14 
07.30 P.M 
19.05.14 
02.30 P.M 
  Yes   No No 
24.  893/14 15 M Single RTA Student Treated 19.05.14 
07.15 A.M 
19.05.14 
03.30 P.M 
 Yes    No No 
25.  895/14 43 M Married RTA Farmer Treated 19.05.14 
06.00 A.M 
19.05.14 
04.00 P.M 
 Yes    No No 
26.  896/14 27 M Married TTA Private Brought 
dead 
19.05.14 
12.05 P.M 
20.05.14 
10.30 A.M 
  Yes   No Yes 
27.  897/14 70 M Married Fall Merchant Treated 19.05.14 
07.15 P.M 
20.05.14 
11.30 A.M 
  Yes   No No 
28.  898/14 25 M Single RTA Painter Treated 19.05.14 
07.10 P.M 
20.05.14 
12.15 P.M 
  Yes   No No 
29.  899/14 65 M NK Natural NK Brought 
dead 
19.05.14 
11.40 A.M 
20.05.14 
12.40 P.M 
   Yes  No No 
30.  900/14 26 M Married RTA Coolie Brought 
dead 
19.05.14 
10.45 P.M 
20.05.14 
12.30 P.M 
  Yes   No No 
31.  901/14 43 M Married Natural Coolie Brought 
dead 
20.05.14 
09.05 A.M 
20.05.14 
01.30 P.M 
Yes     No No 
32.  902/14 28 F Married Snake Bite Coolie Treated 19.05.14 
08.30 P.M 
20.05.14 
01.30 P.M 
  Yes   No No 
33.  903/14 45 M Married Fall Painter Treated 19.05.14 
11.15 P.M 
20.05.14 
02.15 P.M 
  Yes   No No 
34.  905/14 28 F Married TTA Coolie Treated 19.05.14 21.05.14     Yes No No 
03.45 P.M 01.30 P.M 
35.  906/14 19 M Single Snake Bite Coolie Treated 20.05.14 
10.30 P.M 
21.05.14 
01.30 P.M 
  Yes   No No 
36.  907/14 21 M Single RTA Business Brought 
dead 
21.05.14 
07.30 A.M 
21.05.14 
01.40 P.M 
 Yes    No No 
37.  909/14 63 M Married RTA Coolie Treated 21.05.14 
01.15 A.M 
21.05.14 
04.00 P.M 
  Yes   No No 
38.  910/14 44 M Married TTA Govt Brought 
dead 
21.05.14 
11.55 A.M 
22.05.14 
11.00 A.M 
  Yes   No No 
39.  913/14 45 M Married Natural Coolie Brought 
dead 
22.05.14 
10.45 A.M 
22.05.14 
03.30 P.M 
Yes     No No 
40.  915/14 38 M Married Hanging Tailor Treated 22.05.14 
05.30 P.M 
23.05.14 
12 Noon 
  Yes   No No 
41.  916/14 57 M Married Poisoning Tailor Treated 22.05.14 
05.00 P.M 
23.05.14 
12.45 P.M 
  Yes   No No 
42.  917/14 20 M Single RTA Student Treated 23.05.14 
03.50 A.M 
23.05.14 
02.15 P.M 
 Yes    No No 
43.  918/14 42 M Married RTA Driver Treated 23.05.14 
07.40 A.M 
23.05.14 
03.15 P.M 
 Yes    No No 
44.  919/14 
 
60 M Married Murder Coolie Treated 23.05.14 
05.30 A.M 
23.05.14 
03.30 P.M 
 Yes    No No 
45.  920/14 40 M Married Hanging Coolie Brought 
dead 
23.05.14 
07.45 P.M 
24.05.14 
11.00 A.M 
  Yes   No Yes 
46.  921/14 23 M Single Fall Coolie Treated 22.05.14 
08.45 P.M 
24.05.14 
11.15 A.M 
    Yes No No 
47.  922/14 62 M Married RTA Private Treated 23.05.14 
11.00 P.M 
24.05.14 
01.00 P.M 
  Yes   No No 
48.  923/14 45 F Married RTA Tailor Treated 23.05.14 
02.05 P.M 
24.05.14 
12 Noon 
 Yes    No No 
49.  926/14 20 M Single Fall Painter Treated 23.05.14 
05.10 P.M 
24.05.14 
03.00 P.M 
  Yes   No No 
50.  927/14 53 M Married Fall Painter Treated 24.05.14 
07.00 A.M 
25.05.14 
10.30 A.M 
   Yes  No No 
51.  928/14 27 M Married RTA Private Treated 24.05.14 
11.25 P.M 
25.05.14 
11.45 A.M 
  Yes   No No 
52.  931/14 27 F Married Poisoning Coolie Treated 23.05.14 25.05.14     Yes No No 
11.00 P.M 02.15 P.M 
53.  932/14 65 M Married Fall Coolie Treated 25.05.14 
06.00 A.M 
25.05.14 
03.30 P.M 
 Yes    No No 
54.  933/14 45 F Married TTA House wife Brought 
dead 
25.05.14 
11.20 A.M 
25.05.14 
03.45 P.M 
Yes     No No 
55.  934/14 48 F Married Fall Coolie Treated 24.05.14 
10.50 P.M 
25.05.14 
4.15 P.M 
  Yes   No No 
56.  935/14 26 F Married Poisoning Farmer Treated 25.05.14 
01.45 P.M 
26.05.14 
10.15 A.M 
  Yes   No No 
57.  937/14 25 M Single Murder Coolie Treated 25.05.14 
04.35 P.M 
26.05.14 
11.30 A.M 
  Yes   No No 
58.  938/14 49 F Married Poisoning House wife Treated 25.05.14 
02.45 P.M 
26.05.14 
12.15 P.M 
  Yes   No No 
59.  939/14 29 M Single RTA Coolie Treated 25.05.14 
11.00 P.M 
26.05.14 
12.40 P.M 
  Yes   No No 
60.  940/14 62 M Married RTA Security Treated 25.05.14 
09.00 A.M 
26.05.14 
01.45 P.M 
   Yes  No No 
61.  941/14 45 M Married RTA Coolie Treated 25.05.14 
09.30P.M. 
26.05.14 
04.00 P.M 
  Yes   No No 
62.  942/14 37 M Married RTA Driver Treated 26.05.14 
11.30 A.M 
27.05.14 
10.15 A.M 
  Yes   No No 
63.  943/14 45 M Married RTA Merchant Treated 26.05.14 
04.30 P.M 
27.05.14 
12.05 P.M 
  Yes   No No 
64.  947/14 58 M Married Fall Security Brought 
dead 
27.05.14 
05.10 A.M 
27.05.14 
01.40 P.M 
 Yes    No Yes 
65.  948/14 28 M Married Accident Coolie Treated 27.05.14 
05.30 A.M 
27.05.14 
04.00 P.M 
 Yes    No No 
66.  949/14 24 M Single Poisoning Student Treated 27.05.14 
09.00 A.M 
28.05.14 
10.45 A.M 
   Yes  No No 
67.  950/14 18 M Single TTA Coolie Treated 28.05.14 
08.10 A.M 
28.05.14 
11.00 A.M 
Yes     No No 
68.  951/14 57 M Married RTA Govt Treated 27.05.14 
02.45 P.M 
28.05.14 
11.30 A.M 
  Yes   No No 
69.  952/14 65 M Married  Fall Coolie Treated 27.05.14 
07.30 P.M 
28.05.14 
02.30 P.M 
  Yes   No No 
70.  953/14 55 M Married RTA Coolie Treated 28.05.14 28.05.14  Yes    No No 
04.15 A.M 03.45 P.M 
71.  958/14 87 M Married RTA Retd  Treated 28.05.14 
07.00 P.M 
29.07.14 
12.15 P.M 
    Yes No No 
72.  960/14 40 M Married RTA Coolie Treated 28.05.14 
07.30 P.M 
29.05.14 
02.15 P.M 
  Yes   No No 
73.  961/14 18 M Single Electrocut
ion 
Student Treated 29.05.14 
07.20 P.M 
30.05.14 
11.40 A.M 
  Yes   No No 
74.  962/14 65 M Married Fall Govt  Treated 30.05.14 
04.10 A.M 
30.05.14 
01.00 P.M 
 Yes    No No 
75.  963/14 30 M Married RTA Coolie Treated 30.05.14 
04.30 A.M 
30.05.14 
01.30 P.M 
 Yes    No No 
76.  964/14 39 M Married Murder Tailor Treated 29.05.14 
04.00 P.M 
30.05.14 
02.00 P.M 
  Yes   No No 
77.  967/14 22 F Married Poisoning House wife Treated 29.05.14 
07.40 P.M 
30.05.14 
04.30 P.M 
  Yes   No No 
78.  970/14 57 F Married Poisoning House wife Treated 30.05.14 
08.25 P.M 
31.05.14 
01.40 P.M 
  Yes   No Yes 
79.  971/14 55 F Married Snake Bite House  wife Treated 31.05.14 
05.30 A.M 
31.05.14 
03.15 P.M 
 Yes    No No 
80.  973/14 43 M Married RTA Driver Treated 31.05.14 
03.00 P.M 
01.06.14 
10.15 A.M 
  Yes   No No 
81.  974/14 37 M Single Fall Painter Treated 31.05.14 
03.50 P.M 
01.06.14 
11.15 A.M 
  Yes   No No 
82.  975/14 16 M Single Poisoning Student Treated 31.05.14 
09.30 P.M 
01.06.14 
11.40 A.M 
  Yes   No No 
83.  976/14 65 M Married Natural Coolie Brought 
dead 
30.05.14 
09.10 P.M 
01.06.14 
12.15 P.M 
    Yes No No 
84.  977/14 45 M Married RTA Coolie Brought 
dead 
31.05.14 
09.08 A.M 
01.06.14 
01.00 P.M 
   Yes  No No 
85.  978/14 22 M Single RTA Coolie Treated 31.05.14 
05.40 P.M 
01.06.14 
01.30 P.M 
  Yes   No No 
86.  979/14 70 F Married Natural House  wife Brought 
dead 
31.05.14 
03.40P.M. 
01.06.14 
04.00 P.M 
  Yes   No No 
87.  980/14 27 M Married  Poisoning Coolie Treated 01.06.14 
04.30 A.M 
01.06.14 
03.00 P.M 
 Yes    No No 
88.  981/14 30 M Married RTA Coolie Brought 01.06.14 02.06.14   Yes   No No 
dead 08.20 P.M 12.15 P.M 
89.  982/14 60 F Married RTA Coolie Brought 
dead 
01.06.14 
01.30 P.M 
02.06.14 
01.15 P.M 
  Yes   No No 
90.  983/14 35 M Single RTA Coolie Brought 
dead 
01.06.14 
03.00 A.M 
02.06.14 
02.00 P.M 
   Yes  No No 
91.  985/14 34 M Married Natural Coolie Brought 
dead 
02.06.14 
10.45 A.M 
03.06.14 
11.15 A.M 
   Yes  No No 
92.  986/14 38 M Married RTA Business Treated 02.06.14 
09.40 A.M 
03.06.14 
11.40 A.M 
   Yes  No No 
93.  987/14  22 M Single RTA Coolie Treated 02.06.14 
10.35 P.M 
03.06.14 
01.00 P.M 
  Yes   No No 
94.  988/14  45 M Married RTA Coolie Treated 01.06.14 
01.15 P.M 
03.06.14 
01.40 P.M 
    Yes No No 
95.  989/14 22 M Single RTA Driver Brought 
dead 
03.06.14 
04.45 P.M 
03.06.14 
03.30 P.M 
  Yes   No Yes 
96.  990/14 45 F Married RTA House wife Treated 03.06.14 
07.25 A.M 
03.06.14 
04.15 P.M 
 Yes    No No 
97.  991/14 26 M Single RTA Driver Treated 03.06.14 
03.45 P.M 
04.06.14 
12.Noon 
  Yes   No No 
98.  992/14 40 M Married RTA Driver Treated 03.06.14 
09.00 P.M 
04.06.14 
12.30 P.M 
  Yes   No No 
99.  993/14 60 M Married TTA Retd  Brought 
dead 
03.06.14 
07.00 P.M 
04.06.14 
01.30 P.M 
  Yes   No No 
100. 995/14 50 M Married Fall Coolie Treated 04.06.14 
02.35 A.M 
04.06.14 
03.30 P.M 
  Yes   No No 
101. 998/14 45 M Married RTA Coolie Brought 
dead 
04.06.14 
02.25 P.M 
05.06.14 
11.15 A.M 
  Yes   No No 
102. 999/14 42 M Married TTA Coolie Brought 
dead 
04.06.14 
06.05 P.M 
05.06.14 
11.40 A.M 
  Yes   No No 
103. 1000/14 44 M Married RTA Security Treated 04.06.14 
11.00 P.M 
05.06.14 
12.Noon 
  Yes   No No 
104. 1001/14 65 M Married RTA Coolie Treated 04.06.14 
08.15 P.M 
05.06.14 
01.30 P.M 
  Yes   No No 
105. 1002/14 27 M Married  Fall Cleaner Treated 04.06.14 
11.00 A.M 
05.06.14 
02.00 P.M 
   Yes  No No 
106. 1003/14 21 M Single RTA Painter Treated 04.06.14 05.06.14   Yes   No No 
11.00 P.M 02.00 P.M 
107. 1004/14 68 M Married  RTA Private Treated 05.06.14 
06.55 A.M 
05.06.14 
02.30 P.M 
 Yes    No No 
108. 1005/14 30 M Married RTA Coolie Treated 04.06.14 
11.00 A.M 
05.06.14 
02.15 P.M 
   Yes  No No 
109. 1007/14 22 M Single TTA Coolie Treated 05.06.14 
01.20 A.M 
05.06.14 
03.20 P.M 
  Yes   No No 
110. 1009/14 28 M Married RTA Driver Treated 04.06.14 
10.25 P.M 
05.06.14 
04.00 P.M 
  Yes   No No 
111. 1010/14 20 M Single RTA Student Treated 05.06.14 
12.00P.M. 
06.06.14 
04.15 P.M 
   Yes  No No 
112. 1011/14 
 
25 M Married RTA Coolie Treated 05.06.14 
05.45 A.M 
05.06.14 
04.20 P.M 
 Yes    No No 
113. 1013/14 50 M Married RTA Security Treated 05.06.14 
12.40 A.M 
06.06.14 
11,40 A.M 
   Yes  No No 
114. 1014/14 38 M Married RTA Driver Treated 05.06.14 
05.30 P.M 
06.06.14 
12 Noon 
  Yes   No No 
115. 1015/14 41 M Married  RTA Driver Brought 
dead 
05.06.14 
01.10 P.M 
06.06.14 
12.10 P.M 
  Yes   No No 
116. 1016/14 
 
23 M Single RTA Private Treated 06.06.14 
02.40 A.M 
06.06.14 
12.30 P.M 
 Yes    No No 
117. 1019/14 36  M Married Poisoning Coolie Treated 05.06.14 
10.30 P.M 
06.06.14 
01.30 P.M 
  Yes   No No 
118. 1020/14 30 M Married RTA Fish man Treated 05.06.14 
09.00 P.M 
06.06.14 
01.40 P.M 
  Yes   No No 
119. 1021/14 19 M Single Natural Coolie Treated 05.06.14 
11.25 P.M 
06.06.14 
02.00 P.M 
  Yes   No No 
120. 1022/14 52 M Married Fall Driver Treated 05.06.14 
04.30 P.M 
06.06.14 
04.15 P.M 
  Yes   No No 
121. 1023/14 22 M Single TTA Coolie Brought 
dead 
07.06.14 
07.15 A.M 
07.06.14 
10.45 A.M 
Yes     No No 
122. 1025/14 45 M Married Fall Business Treated 06.06.14 
04.00 A.M 
07.06.14 
12.30 P.M 
   Yes  No No 
123. 1026/14 55 M Married Natural Coolie Brought 
dead 
06.06.14 
05.10 P.M 
07.06.14 
12.30 P.M 
  Yes   No No 
124. 1028/14 
 
55 M NK Natural NK Brought 
dead 
30.05.14 
11.45 A.M 
07.06.14 
01.30 P.M 
    Yes No NO 
125. 1032/14 45 M Married RTA Private Treated 06.06.14 
09.30 P.M 
07.06.14 
02.15 P.M 
  Yes   No No 
126. 1034/14 
 
55 F Married RTA Coolie Treated 06.06.14 
04.00P.M 
07.06.14 
02.45P.M 
  Yes   No No 
127. 1035/14 27 M Married Electrocut
ion 
Coolie Treated 06.06.14 
08.20 P.M 
07.06.14 
03.15 P.M 
  Yes   No No 
128. 1036/14 60 M Married Natural  Driver Brought 
dead 
06.06.14 
09.10 P.M 
07.06.14 
03.45 P.M 
  Yes   No No 
129. 1038/14 
 
23 M Married RTA Driver Treated 07.06.14 
12.30 P.M 
08.06.14 
11.30 A.M 
  Yes   No No 
130. 1039/14 35 F Married RTA Coolie Treated 07.06.14 
09.45 P.M 
08.06.14 
11.40 A.M 
  Yes   No No 
131. 1040/14 38 F NK Murder NK Treated 07.06.14 
07.00 A.M 
08.06.14 
11.40 A.M 
   Yes  No No 
132. 1041/14 63 M Married Murder Private  
 
Treated 08.06.14 
12.15 A.M 
08.06.14 
12.40 P.M 
  Yes   No No 
133. 1042/14 20 M Single  RTA Coolie Treated 08.06.14 
07.40 A.M 
08.06.14 
01.30 P.M 
Yes     No No 
134. 1043/14 50 M Married Poisoning Coolie Treated 08.06.14 
02.20 A.M 
08.06.14 
01.30 P.M 
 Yes    No No 
135. 1044/14 33 M Married TTA Coolie Brought 
dead 
08.06.14 
10.30 A.M 
08.06.14 
02.00 P.M 
Yes     No No 
136. 1045/14 42 M Married RTA Coolie Treated 08.06.14 
12.15 A.M 
08.06.14 
02.30 P.M 
  Yes   No No 
137. 1046/14 50 F Married RTA House wife Treated 08.06.14 
07.50 A.M 
09.06.14 
11.30 A.M 
   Yes  No No 
138. 1047/14 50 M Married RTA Farmer Treated 08.06.14 
01.15 P.M 
09.06.14 
11.30 A.M 
  Yes   No No 
139. 1050/14 53 M Married TTA Security Brought 
dead 
09.06.14 
11.10 A.M 
09.06.14 
03.00 P.M 
Yes     No No 
140. 1051/14 35 M Married RTA Coolie Treated 09.06.14 
02.25 A.M 
10.06.14 
12.00 P.M 
   Yes  No No 
141. 1052/14 60 M Married RTA Farmer Treated 09.06.14 
11.25 A.M 
10.06.14 
12.30 P.M 
   Yes  No No 
142. 1053/14 32 M Married Murder Coolie Treated 09.06.14 
01.10 A.M 
10.06.14 
12.30 P.M 
  Yes   No No 
143. 1055/14 43 M Married Natural Driver Treated 09.06.14 
10.45 A.M 
10.06.14 
01.30 P.M 
   Yes  No No 
144. 1058/14 45 M Married Fall Coolie Treated 10.06.14 
09.30 A.M 
10.06.14 
04.00 P.M 
 Yes    No No 
145. 1059/14 21 M Married RTA Coolie Treated 09.06.14 
04.30 P.M 
10.06.14 
04.15 P.M 
  Yes   No No 
146. 1060/14 
 
45 M Married Poisoning Driver Treated 10.06.14 
12.15 A.M 
10.06.14 
04.30 P.M 
  Yes   No No 
147. 1061/14 35 F Married Poisoning Coolie Brought 
dead 
10.06.14 
12.30 A.M 
10.06.14 
04.45 P.M 
  Yes   No Yes 
148. 1063/14 62 M Married RTA Retd Treated 10.06.14 
08.45 P.M 
11.06.14 
11.30 A.M 
  Yes   No No 
149. 1064/14 51 M Married RTA Coolie Treated 11.06.14 
01.45 A.M 
11.06.14 
11.40 A.M 
 Yes    No No 
150. 1067/14 60 M Married RTA Coolie Treated 11.06.14 
01.00 A.M 
11.06.14 
01.15 P.M 
  Yes   No No 
151. 1068/14 45 M Married RTA Driver Treated 10.06.14 
08.20 P.M 
11.06.14 
03.30 P.M 
  Yes   No No 
152. 1069/14 43 M Married Natural  Driver Brought 
dead 
11.06.14 
12 Noon 
12.06.14 
11.00 A.M 
  Yes   No Yes 
153. 1071/14 19 M Single RTA Coolie Treated 11.06.14 
01.30 P.M 
12.06.14 
11.30 A.M 
  Yes   No No 
154. 1072/14 45 M Married RTA Coolie Treated 11.06.14 
10.00 A.M 
12.06.14 
12 Noon 
   Yes  No No 
155. 1074/14 58 M Married RTA Coolie Treated 11.06.14 
01.00 P.M 
12.06.14 
01.30 P.M 
   Yes  No No 
156. 1075/14 24 M Married RTA Coolie Brought 
dead 
12.06.14 
09.25 A.M 
12.06.14 
01.30 P.M 
 Yes    No No 
157. 1079/14 43 M Married TTA Coolie Treated 12.06.14 
04.00 A.M 
12.06.14 
03.30 P.M 
 Yes    No No 
158. 1080/14 65 M Married Natural Retd Brought 
dead 
12.06.14 
09.00 A.M 
13.06.14 
11.30 A.M 
   Yes  No No 
159. 1081/14 58 M Married Fall Coolie Treated 12.06.14 
01.05 P.M 
13.06.14 
11.00 A.M 
  Yes   No No 
160. 1082/14 
 
23 M Single RTA Private Treated 12.06.14 
02.00P.M 
13.06.14 
12 Noon 
  Yes    No No 
161. 1083/14 42 M Married Electrocut
ion 
Coolie Brought 
dead 
12.06.14 
03.15 P.M 
13.06.14 
12 Noon 
  Yes   No No 
162. 1084/14 53 M Married TTA Govt Brought 
dead 
13.06.14 
01.45 P.M 
13.06.14 
02.45 P.M 
Yes     No No 
163. 1085/14 50  M Married Murder Private Treated 12.06.14 
11.40 A.M 
13.06.14 
03.00 P.M 
   Yes  No No 
164. 1088/14 65 M Married Fall Coolie Treated 13.06.14 
12.35 P.M 
14 06.14 
11.00 A.M 
  Yes   No No 
165. 1090/14 65 M Married Poisoning Coolie Treated 13.06.14 
01.40 P.M 
14.06.14 
12 Noon 
  Yes   No No 
166. 1091/14 25 M Married RTA Driver Treated 14.06.14 
02.30 A.M 
14.06.14 
12.30 P.M 
 Yes    No No 
167. 1093/14 
 
35 M Married Natural Coolie Brought 
dead 
13.06.14 
06.00 P.M 
14.06.14 
02.30 P.M 
  Yes   No No 
168. 1095/14 45 M Married RTA Coolie Treated 14.06.14 
06.10 A.M 
14.06.14 
03.30 P.M 
 Yes    No No 
169. 1096/14 18 M Single TTA Student Brought 
dead 
14.06.14 
09.05 P.M 
15.06.14 
10.45A.M 
  Yes   No No 
170. 1098/14 28 M Married RTA Carpenter Treated 14.06.14 
06.10 P.M 
15.06.14 
01.00 P.M 
  Yes   No No 
171. 1101/14 48 M Married RTA Coolie Brought 
dead 
15.06.14 
09.50 A.M 
15.06.14 
03.40 P.M 
Yes     No No 
172. 1103/14 44 M Married RTA Mason Treated 15.06.14 
12.18 P.M 
16.06.14 
12.35 P.M 
   Yes  No No 
173. 1104/14 
 
60 M Married Fall Security Treated 16.06.14 
12.10.A.M 
16.06.14 
12.55 P.M 
  Yes   No No 
174. 1105/14 
 
18 M Single RTA Coolie Treated 15.06.14 
08.00 P.M 
16.06.14 
01.30 P.M 
  Yes   No No 
175. 1106/14 27 Tra
nsg
Single Hanging Coolie Treated 15.06.14 
08.50 P.M 
16.06.14 
01.30 P.M 
  Yes   No Yes 
end
er 
176. 1107/14 80 M Married RTA Farmer Treated 16.06.14 
05.30 A.M 
16.06.14 
02.10 P.M 
 Yes    No No 
177. 1109/14 48 M Married Natural Govt Brought 
dead 
14.06.14 
11.00 A.M 
16.06.14 
02.35 P.M 
    Yes No No 
178. 1111/14 29 M Married RTA Coolie Treated 16.06.14 
08.10 A.M 
17.06.14 
11.10 A.M 
   Yes  No No 
179. 1112/14 
 
32 M Married Hanging Driver Treated 16.06.14 
05.00 A.M 
17.06.14 
12.10 P.M 
   Yes  No No 
180. 1113/14 45 M Married RTA Coolie Treated 16.06.14 
07.25 A.M 
17.06.14 
12.35 P.M 
   Yes  No No 
181. 1114/14 
 
30 M Married Fall Coolie Treated 16.06.14 
05.05 P.M 
17.06.14 
01.00 P.M 
  Yes   No No 
182. 1115/14 
 
25 F Married Poisoning House wife Treated 16.06.14 
04.00 P.M 
17.06.14 
03.30 P.M 
  Yes   No No 
183. 1116/14 
 
30 M Married RTA Goldsmith Treated 16.06.14 
11.10 P.M 
17.06.14 
03.40 P.M 
  Yes   No No 
184. 1118/14 
 
37 M Married RTA Electrician Treated 17.07.14 
12.30 P.M 
18.06.14 
10.30 A.M 
  Yes   No No 
185. 1119/14 
 
23 M Married RTA Coolie Treated 17.06.14 
03.50 P.M 
18.06.14 
12.40 P.M 
  Yes   No No 
186. 1120/14 25 M Married Suspicious 
death 
Driver Brought 
dead 
17.06.14 
07.00 A.M 
18.06.14 
12.55 P.M 
   Yes  No No 
187. 1121/14 76 M Married RTA Farmer Treated 17.06.14 
11.45 A.M 
18.06.14 
02.50 P.M 
   Yes  No No 
188. 1123/14 
 
32 M Married RTA Electrician Treated 18.06.14 
02.20 A.M 
18.06.14 
03.50 P.M 
  Yes   No No 
189. 1124/14 
 
60 F Married TTA Coolie Treated 18.06.14 
08.30 A.M 
18.06.14 
03.50 P.M 
 Yes    No No 
190. 1125/14 
 
41 M Married RTA Coolie Treated 18.06.14 
06.35 A.M 
19.06.14 
10.40 A.M 
   Yes  No No 
191. 1126/14 
 
54 M Married Fall Cine Field Treated 18.06.14 
08.15 P.M 
19.06.14 
12.45 P.M 
  Yes   No No 
192. 1127/14 
 
50 M Married RTA Driver Treated 19.06.14 
07.10 A.M 
19.06.14 
02.40 P.M 
 Yes    No No 
193. 1128/14 
 
50 M Married RTA Coolie Treated 19.06.14 
02.00 A.M 
19.06.14 
03.10 P.M 
  Yes   No No 
194. 1130/14 
 
64 M Married RTA Mechanic Treated 19.06.14 
10.40 A.M 
20.06.14 
11.00 A.M 
   Yes  No No 
195. 1131/14 
 
24 F Married Poisoning House wife Treated 18.06.14 
02.15 A.M 
20.06.14 
11.30 A.M 
    Yes No No 
196. 1132/14 
 
32 M Married RTA Coolie Treated 19.06.14 
04.00 P.M 
20.06.14 
12.15 P.M 
  Yes   No No 
197. 1133/14 13 M Single RTA Student Brought 
dead 
19.06.14 
04.35 P.M 
20.06.14 
12.10 P.M 
  Yes   No No 
198. 1134/14 25 M Single RTA Private Treated 19.06.14 
06.05 A.M 
20.06.14 
12.40 P.M 
   Yes  No No 
199. 1135/14 
 
55 M Married Natural  Coolie Brought 
dead 
19.06.14 
12.35 P.M 
20.06.14 
01.10 P.M 
   Yes  No No 
200. 1136/14 
 
50 M Married RTA Private Treated 20.06.14 
01.30 A.M 
20.06.14 
01.10 P.M 
 Yes    No No 
201. 1137/14 
 
62 M Married  RTA Security Treated 20.06.14 
12.35 A.M 
20.06.14 
01.40 P.M 
  Yes   No No 
202. 1138/14 
 
34 M Married RTA Coolie Treated 19.06.14 
09.45 A.M 
20.06.14 
01.30 P.M 
   Yes  No No 
203. 1146/14 58 M Married RTA Coolie Treated 21.06.14 
01.30 A.M 
21.06.14 
12.10P.M 
 Yes    No No 
204. 1148/14 45 M Married RTA Farmer Treated 21.06.14 
04.30 A.M 
21.06.14 
02.40 P.M 
 Yes    No No 
205. 1150/14 
 
54 M Married RTA Tailor Brought 
dead 
21.06.14 
12.40 P.M 
22.06.14 
10.30 A.M 
  Yes   No No 
206. 1151/14 
 
40 M Married RTA Painter Treated 21.06.14 
02.35 P.M 
22.06.14 
12.45 P.M 
  Yes   No No 
207. 1152/14 35 M Married Poisoning Coolie Treated 21.06.14 
09.15 P.M 
22.06.14 
02.30 P.M 
  Yes   No No 
208. 1153/14 40 M Married RTA Driver Treated 21.06.14 
11.30 P.M 
22.06.14 
03.30 P.M 
  Yes   No No 
209. 1154/14 
 
55 F Married Suspicious 
Death 
Coolie Treated 22.06.14 
10.20 A.M 
23.06.14 
10.40 A.M 
   Yes  No No 
210. 1155/14 35 
 
M Married RTA Coolie Treated 22.06.14 
05.30 P.M 
23.06.14 
11.10 A.M 
  Yes   No No 
211. 1156/14 45 
 
F Married RTA House wife Treated 22.06.14 
02.30 P.M 
23.06.14 
11.40 A.M 
  Yes   No No 
212. 1158/14 18 
 
M Single RTA Private Treated 22.06.14 
08.00 P.M 
23.06.14 
01.00 P.M 
  Yes   No No 
213. 1159/14 22 M Married Poisoning Coolie Treated 22.06.14 
06.50 A.M 
23.06.14 
02.10 P.M 
   Yes  No No 
214. 1160/14 25 
 
M Married RTA Farmer Treated 22.06.14 
10.55 A.M 
23.06.14 
01.30 P.M 
   Yes  No No 
215. 1161/14 42 
 
M Married RTA Coolie Treated 23.06.14 
01.55 A.M 
23.06.14 
03.00 P.M 
  Yes   No No 
216. 1162/14 42 F Married RTA House wife Treated 23.06.14 
06.15 A.M 
23.06.14 
02.40 P.M 
 Yes    No No 
217. 1163/14 45 
 
M Married RTA Driver Treated 23.06.14 
05.30 A.M 
23.06.14 
03.15 P.M 
 Yes    No No 
218. 1164/14 60 M Married RTA Tailor Brought 
dead 
23.06.14 
07.15 A.M 
23.06.14 
03.00 P.M 
 Yes    No No 
219. 1165/14 23 
 
F Single Poisoning Coolie Treated 22.06.14 
12.00 A.M 
23.06.14 
03.40 P.M 
    Yes No No 
220. 1166/14 73 M Married RTA Coolie Treated 23.06.14 
09.30 A.M 
24.06.14 
10.30 A.M 
   Yes  No No 
221. 1167/14 40 M Married Natural Coolie Brought 
dead 
23.06.14 
02.30 P.M 
24.06.14 
10.40 A.M 
  Yes   No No 
222. 1169/14 24 M Single Burns Coolie Brought 
dead 
24.06.14 
10.30 A.M 
24.06.14 
01.10 P.M 
Yes     No No 
223. 1171/14 
 
62 M Married RTA Business Treated 24.06.14 
06.50 A.M 
24.06.14 
02.10 P.M 
 Yes    No No 
224. 1172/14 45 M Married Fall Farmer Treated 24.06.14 
09.48 A.M 
25.06.14 
10.20 A.M 
   Yes  No No 
225. 1173/14 34 
 
M Married Murder Coolie Treated 25.06.14 
05.30 A.M 
25.06.14 
12.30 P.M 
 Yes    No Yes 
226. 1174/14 40 M Married RTA Painter Treated 24.06.14 
08.15 A.M 
25.06.14 
01.10 P.M 
   Yes  No No 
227. 1175/14 54 
 
M Married RTA Coolie Treated 24.06.14 
04.00 P.M 
25.06.14 
01.40 P.M 
  Yes   No No 
228. 1176/14 38 
 
M Married RTA Mason Treated 24.06.14 
04.45 P.M 
25.06.14 
03.00 P.M 
  Yes   No No 
229. 1177/14 60 
 
M Married RTA Coolie Treated 25.06.14 
10.25 A.M 
26.06.14 
11.10 A.M 
   Yes  No No 
230. 1178/14 21 
 
M Single Murder Coolie Treated 25.06.14 
06.30 P.M 
26.06.14 
11.40 A.M 
  Yes   No No 
231. 1182/14 73 
 
M Married RTA Coolie Treated 25.06.14 
08.40 P.M 
26.06,14 
01.30 P.M 
  Yes   No No 
232. 1184/14 58 M Married Fall Tailor Treated 26.06.14 
08.20 A.M 
26.06.14 
03.45 P.M 
 Yes    No No 
233. 1186/14 55 
 
M Married RTA Coolie Brought 
dead 
26.06.14 
08.30 P.M 
27.06.14 
03.00 P.M 
  Yes   No No 
234. 1187/14 10 
 
M Single RTA Student Brought 
dead 
27.06.14 
07.30 A.M 
27.06.14 
03.30 P.M 
 Yes    No No 
235. 1189/14 45 M Married RTA Private Treated 27.06.14 
10.30 A.M 
28.06.14 
10.40 A.M 
   Yes  No No 
236. 1190/14 53 M Married RTA Private Treated 27.06.14 
02.30 P.M 
28.06.14 
11.10 A.M 
  Yes   No No 
237. 1192/14 47 M Married Natural  Coolie Brought 
dead 
27.06.14 
07.15 P.M 
28.06.14 
11.40 A.M 
  Yes   No Yes 
238. 1196/14 77 M Married TTA Coolie Brought 
dead 
29.06.14 
07.30 A.M 
29.06.14 
12.55 P.M 
Yes     No No 
239. 1197/14 
 
25 M Single Fall Coolie Treated 29.06.14 
04.40 P.M 
30.06.14 
11.30 A.M 
  Yes   No No 
240. 1199/14 11 M Single RTA Student Treated 29.06.14 
10.30 P.M 
30.06.14 
01.10 P.M 
 
 
 Yes   No No 
241. 1200/14 57 M Married Fall Coolie Treated 29.06.14 
08.30 P.M 
30.06.14 
02.10 P.M 
  Yes   No No 
242. 1202/14 
 
73 F Married Fall Coolie Treated 29.06.14 
06.00 P.M 
30.06.14 
02.00 P.M 
  Yes   No No 
243. 1203/14 28 M Married RTA Driver Treated 30.06.14 
06.45 A.M 
30.06.14 
03.10 P.M 
 Yes    No No 
244. 1204/14 40 M Married RTA Private Treated 30.06.14 
03.40 A.M 
30.06.14 
03.30 P.M 
 Yes    No No 
245. 1205/14 47 M Married Poisoning Painter Treated 30.06.14 
11.00 A.M 
30.06.14 
04.00 P.M 
Yes     No No 
246. 1206/14 60 M Married RTA Coolie Treated 29.06.14 
08.00 P.M 
01.07.14 
11.15 A.M 
    Yes No No 
247. 1207/14 
 
22 M Single RTA Coolie Treated 30.06.14 
11.50 P.M 
01.07.14 
11.40 A.M 
 Yes    No No 
248. 1208/14 
 
45 M Married RTA Coolie Treated 30.06.14 
06.10 P.M 
01.07.14 
12 Noon  
  Yes   No No 
249. 1209/14 32 M Married Murder Coolie Treated 30.06.14 
10.45 P.M 
01.07.14 
12.10 P.M 
  Yes   No No 
250. 1210/14 30 M Married RTA Mason Treated 30.06.14 
03.50 P.M 
01.07.14 
12.40 P.M 
  Yes   No No 
251. 1211/14 35 M Married RTA Coolie Treated 30.06.14 
04.25 P.M 
01.07.14 
01.30 P.M 
  Yes   No No 
252. 1212/14 54 M Married RTA Farmer Treated 30.06.14 
09.50 A.M 
01.07.14 
01.30 P.M 
   Yes  No No 
253. 1214/14 65 
 
M Married Natural Coolie Treated 28.06.14 
12.30 P.M 
01.07.14 
02.00 P.M 
    Yes No No 
254. 1216/14 45 F Married RTA Coolie Treated 01.07.14 
06.30 A.M 
01.07.14 
04.30 P.M 
 Yes    No No 
255. 1217/14 22 M Single RTA Private Treated 01.07.14 
12.30 P.M 
02.07.14 
11.10 A.M 
 Yes    No No 
256. 1218/14 50 
 
M Married Fall Coolie Treated 01.07.14 
10.55 P.M 
02.07.14 
11.40 A.M 
  Yes   No No 
257. 1219/14 58 
 
M Married RTA Coolie Treated 01.07.14 
05.40 A.M 
02.07.14 
12.10 P.M 
   Yes  No No 
258. 1220/14 35  M Married RTA Coolie Treated 01.07.14 
07.20 A.M 
02.07.14 
12.30 P.M 
   Yes  No No 
259. 1221/14 
 
36 M Married Hanging Coolie Treated 01.07.14 
11.10 A.M 
02.07.14 
12.40 P.M 
   Yes  No No 
260. 1222/14 
 
42 M
M 
Married RTA Coolie Treated 01.07.14 
03.15 P.M 
02.07.14 
01.10 P.M 
  Yes   No No 
261. 1224/14 
 
15 M Single RTA  Student Brought 
dead 
02.07.14 
08.30 A.M 
02.07.14 
02.10 P.M 
Yes     No No 
262. 1225/14 46 M Married RTA Coolie Treated 02.07.14 
05.30 A.M 
03.07.14 
11.30 A.M 
   Yes  No No 
263. 1227/14 
 
58 M Married RTA Govt  Treated 02.07.14 
04.15 P.M 
03.07.14 
11.40 A.M 
  Yes   No No 
264. 1228/14 72 M Married RTA  Private Brought 
dead 
02.07.14 
12.20 P.M 
03.07.14 
11.30 A.M 
  Yes   No No 
265. 1229/14 25 
 
F Single TTA Student Brought 
dead 
02.07.14 
02.10 P.M 
03.07.14 
12.20 P.M 
  Yes   No No 
266. 1230/14 70 
 
M Married RTA Coolie Treated 02.07.14 
03.30 P.M 
03.07.14 
01.00 P.M 
  Yes   No No 
267. 1231/14 22 
 
M Single Fall  Painter Brought 
dead 
02.07.14 
02.45 P.M 
03.07.14 
01.10 P.M 
  Yes   No No 
268. 1233/14 58 
 
M Married RTA Private Treated 03.07.14 
03.55 A.M 
03.07.14 
02.10 P.M 
 Yes    No No 
269. 1234/14 42 
 
M Married Hanging  Fish man Brought 
dead 
03.07.14 
11.00 A.M 
03.07.14 
03.30 P.M 
Yes     No Yes 
270. 1235/14 36 M Married RTA Coolie Treated 03.07.14 
06.25 A.M 
03.07.14 
04.30 P.M 
   Yes  No No 
271. 1236/14 30 M Married RTA  Coolie Treated 03.07.14 
02.35 P.M 
04.07.14 
11.15 A.M 
  Yes   No No 
272. 1238/14 
 
27 M Single RTA Coolie Treated 03.07.14 
11.00 A.M 
04.07.14 
12 Noon 
   Yes  No No 
273. 1239/14 44 M Married RTA Private Treated 03.07.14 
09.00 P.M 
04.07.14 
12.30 P.M 
  Yes   No No 
274. 1240/14 
 
50 M Married RTA Farmer Treated 03.07.14 
06.10 A.M 
04.07.14 
01.30 P.M 
   Yes  No No 
275. 1241/14 8 F Single RTA  Student Brought 
dead 
04.07.14 
01.25 P.M 
04.07.14 
03.00 P.M 
Yes     No No 
276. 1242/14 65 M Married Natural  Coolie Brought 
dead 
04.07.14 
06.55 A.M 
04.07.14 
03.30 P.M 
 Yes    No No 
277. 1244/14  
 
26 F Married Murder  Sex worker Brought 
dead 
04.07.14 
01.50 P.M 
05.07.14 
01.10 P.M 
  Yes   No Yes 
278. 1246/14 37 M Married Fall Coolie Treated 04.07.14 
05.15 P.M 
05.07.14 
03.30 P.M 
  Yes   No No 
279. 1247/14 55 M Married RTA Private Treated 05.07.14 
09.05 P.M 
06.07.14 
11.40 A.M 
  Yes   No No 
280. 1248/14 34 F Married Hanging  Private Brought 
dead 
05.07.14 
07.05 P.M 
06.07.14 
12.30 P.M 
  Yes   No No 
281. 1249/14 48 M Married RTA Coolie Treated 06.07.14 
04.30 A.M 
06.07.14 
01.30 P.M 
 Yes    No No 
282. 1252/14 
 
52 M Married RTA Coolie Treated 06.07.14 
09.30 P.M 
07.07.14 
12.30 P.M 
  Yes   No No 
283. 1253/14 
 
52 M Married Poisoning Driver Treated 06.07.14 
09.45 A.M 
07.07.14 
12.30 P.M 
   Yes  No No 
284. 1254/14 
 
32 M Single Fall Carpenter Treated 06.07.14 
09.10 A.M 
07.07.14 
03.10 P.M 
   Yes  No No 
285. 1255/14 22 M Single Fall Carpenter Treated 06.07.14 
09.10 A.M 
07.07.14 
03.30 P.M 
   Yes  No No 
286. 1256/14 36 F Married Electrocut
ion 
Coolie Treated 07.07.14 
07.30A.M. 
07.07.14 
O4.00P.M 
 Yes    No No 
287. 1257/14 18 M Single RTA Private Treated 08.07.14 
01.30 A.M 
08.07.14 
12.15 P.M 
 Yes    No No 
288. 1272/14 42 M Married Natural Carpenter Treated 08.07.14 
06.00 A.M 
08.07.14 
02.40 P.M 
 Yes    No No 
289. 1274/14 45 M Married Snake Bite Coolie Treated 08.07.14 
11.30 P.M 
09.07.14 
12 Noon 
  Yes   No No 
290. 1276/14 68 M Married Natural Private Treated 09.07.14 
09.50 A.M 
09.07.14 
01.15 P.M 
Yes     No No 
291. 1277/14 52 M Married Poisoning Coolie Treated 09.07.14 
07.40 A.M 
09.07.14 
02.15 P.M 
 Yes    No No 
292. 1279/14 65 M Married Fall Coolie Treated 09.07.14 
03.25 A.M 
09.07.14 
02.45 P.M  
 Yes    No No 
293. 1280/14 28 M Married RTA Coolie Treated 08.07.14 
05.15 P.M 
09.07.14 
03.00 P.M 
  Yes   No No 
294. 1281/14 18 M Single TTA Student Treated 09.07.14 
06.00 A.M 
09.07.14 
03.40 P.M 
 Yes    No No 
295. 1282/14 40 M Married RTA Coolie Treated 09.07.14 
01.00 P.M 
10.07.14 
11.30 A.M 
  Yes   No No 
296. 1283/14 47 M Married RTA Private Treated 09.07.14 
04.10 P.M 
10.07.14 
11.30 A.M 
  Yes   No No 
297. 1284/14 34 
 
M Married Murder  Driver Brought 
dead 
09.07.14 
06.45 P.M 
10.07.14 
12.30 P.M 
  Yes   No Yes 
298. 1285/14 65 F Married RTA Coolie Treated 10.07.14 
05.30 A.M 
10.07.14 
01.00 P.M 
 Yes    No No 
299. 1287/14 34 M Married RTA Driver Treated 09.07.14 
06.45 P.M 
10.07.14 
12.15 P.M 
  Yes   No No 
300. 1288/14 59 M Married Fall Coolie Treated 10.07.14 
07.10 A.M 
10.07.14 
01.40 P.M 
 Yes    No No 
301. 1289/14 48 M Married Fall Mason Treated 09.07.14 
05.25 P.M 
10.07.14 
02.00 P.M 
  Yes   No No 
302. 1290/14 53 M Married RTA Farmer Treated 09.07.14 
03.00 P.M 
10.07.14 
02.10 P.M 
  Yes   No No 
303. 1291/14 53 M Married RTA Farmer Treated 09.07.14 
03.00 P.M 
10.07.14 
02.15 P.M 
  Yes   No No 
304. 1292/14 28 F Married Hanging  House wife Brought 
dead 
09.07.14 
11.35 P.M 
10.07.14 
04.30 P.M 
  Yes   No No 
305. 1293/14 59 F Married RTA House wife Treated 09.07.14 
09.50 P.M 
10.07.14 
04.30 P.M 
  Yes   No No 
306. 1294/14 18 F Single Hanging Coolie Treated 10.07.14 
04.25 P.M 
11.07.14 
11.30 A.M 
  Yes   No No 
307. 1297/14 49 M Married RTA Coolie Treated 10.07.14 
10.30 P.M 
11.07.14 
01.30 P.M 
  Yes   No No 
308. 1298/14 73 M Married Snake Bite Coolie Treated 11.07.14 
06.10 A.M 
11.07.14 
02.00 P.M 
 Yes    No No 
309. 1300/14 
 
46 M Married Fall Coolie Treated 11.07.14 
02.00 P.M 
12.07.14 
11.15 A.M 
  Yes   No No 
310. 1303/14 
 
48 M Married Snake Bite Coolie Treated 11.07.14 
04.10 P.M 
12.07.14 
01.40 P.M 
  Yes   No No 
311. 1304/14 
 
24 M Single Poisoning Coolie Treated 11.07.14 
03.30 P.M 
12.07.14 
02.40 P.M 
  Yes   No No 
312. 1305/14 58 M Married RTA Private Treated 12.07.14 
12.30 A.M 
12.07.14 
04.00 P.M 
  Yes   No No 
313. 1308/14 35 F Married Natural  Coolie Treated 12.07.14 
07.35 P.M 
13.07.14 
02.00 P.M 
  Yes   No No 
314. 1309/14 
 
61 M Married Fall  Broker Brought 
dead 
13.07.14 
01.30 A.M 
13.07.14 
02.10 P.M 
  Yes   No No 
315. 1311/14 38 M Married TTA  Private Brought 
dead 
13.07.14 
09.00 A.M 
13.07.14 
03.30 P.M 
 Yes    No No 
316. 1312/14 
 
21 M Single RTA Coolie Treated 13.07.14 
10.30 A.M 
14.07.14 
11.00 A.M 
   Yes  No No 
317. 1313/14 28 M Single Fall Private Treated 13.07.14 
11.53 P.M 
14.07.14 
11.15 A.M 
  Yes   No No 
318. 1314/14 40 M Married Natural Private Treated 14.07.14 
01.05 A.M 
14.07.14 
11.40 A.M 
 Yes    No No 
319. 1315/14 36 M Married TTA Private Brought 
dead 
13.07.14 
07.00 P.M 
14.07.14 
12 Noon  
  Yes   No No 
320. 1316/14 26 M Single RTA  Private Brought 
dead 
13.07.14 
01.00 P.M 
14.07.14 
12.30 P.M 
  Yes   No No 
321. 1317/14 
 
42 F Married Natural House wife Treated 13.07.14 
05.30 P.M 
14.07.14 
12.15 P.M 
  Yes   No No 
322. 1318/14 
 
65 M Married Poisoning Coolie Treated 13.07.14 
12.45 P.M 
14.07.14 
01.10 P.M 
   Yes  No No 
323. 1319/14 25 M Married Electrocut
ion 
Coolie Treated 13.07.14 
08.00 P.M 
14.07.14 
01.30 P.M 
  Yes   No No 
324. 1320/14 23 M Single RTA Driver Treated 13.07.14 
10.45 P.M 
14.07.14 
01.40 P.M 
  Yes   No No 
325. 1321/14 18 M Single Poisoning Coolie Treated 14.07.14 
05.20 A.M 
14.07.14 
02.30 P.M 
 Yes    No No 
326. 1323/14 18 M Single RTA Student Treated 14.07.14 
08.15 P.M 
15.07.14 
12.15 P.M 
  Yes   No No 
327. 1324/14 23 M Married RTA Coolie Treated 14.07.14 
04.45 P.M 
15.07.14 
12.30 P.M 
  Yes   No No 
328. 1326/14 36 M Married Fall Coolie Treated 14.07.14 
10.00 P.M 
15.07.14 
01.30 P.M 
  Yes   No No 
329. 1329/14 50 M Married RTA Private Treated 15.07.14 
12.15 A.M 
15.07.14 
02.40 P.M 
 
 
 Yes   No No 
330. 1330/14 46 M Married Fall Private Treated 15.07.14 
02.30 A.M 
15.07.14 
03.30 P.M 
 Yes    No No 
331. 1331/14 35 M Married Natural Private Treated 15.07.14 
02.45 A.M 
15.07.14 
03.30 P.M 
 Yes    No No 
332. 1332/14 60 M Married Natural Coolie Treated 15.07.14 
06.00 A.M 
16.07.14 
12.10 P.M 
   Yes  No No 
333. 1334/14 60 M NK Natural NK Treated 15.07.14 
06.15 A.M 
16.07.14 
12.30 P.M 
   Yes  No Yes 
334. 1338/14 27 F Married Poisoning House wife Treated 15.07.14 
03.00 P.M 
16.07.14 
04.30 P.M 
   Yes  No No 
335. 1340/14 66 M Married Fall Fish man Treated 16.07.14 
07.15 P.M 
17.07.14 
11.30 A.M 
  Yes   No No 
336. 1341/14 32 M Married Hanging Private Treated 17.07.14 
06.10 A.M 
17.07.14 
03.30 P.M 
 Yes    No No 
337. 1343/14 37 M Married RTA Private Treated 17.07.14 
06.20 A.M 
18.07.14 
11.40 A.M 
   Yes  No No 
338. 1345/14 35 M Single RTA Private Treated 15.07.14 
09.15 A.M 
18.07.14 
12.30 P.M 
    Yes No No 
339. 1346/14 31 M Married RTA Private Treated 18.07.14 
05.00 A.M 
18.07.14 
12.40 P.M 
 Yes    No No 
340. 1348/14 45 M Single Natural Coolie Treated 16.07.14 
08.15 P.M 
18.07.14 
02.00 P.M 
    Yes No No 
341. 1349/14 26 M Single TTA Private Brought 
dead 
18.07.14 
12.50 P.M 
18.07.14 
01.40 P.M 
Yes     No No 
342. 1352/14 
 
70 M Married Snake Bite Coolie Treated 18.07.14 
12.15 P.M 
19.07.14 
11.15 A.M 
  Yes   No No 
343. 1353/14 57 M 
 
Married RTA Govt Treated 18.07.14 
11.50 A.M 
19.07.14 
11.25 A.M 
  Yes   No No 
344. 1354/14 
 
36 M Single RTA Private Treated 18.07.14 
03.15 P.M 
19.07.14 
12.30 P.M 
  Yes   No No 
345. 1355/14 
 
40 M Married Fall Coolie Treated 18.07.14 
03.30 P.M 
19.07.14 
12.15 P.M 
  Yes   No No 
346. 1356/14 54 F Married Snake Bite Coolie Treated 18.07.14 
06.50 P.M 
19.07.14 
12.40 P.M 
  Yes   No No 
347. 1358/14 29 M Single RTA 
 
Private Brought 
dead 
18.07.14 
04.45 P.M 
19.07.14 
02.00 P.M 
  Yes   No No 
348. 1359/14 
 
38 M Married RTA Coolie Treated 18.07.14 
01.00 P.M 
19.07.14 
03.00 P.M 
   Yes  No No 
349. 1360/14 51 F Married RTA Private Treated 19.07.14 
06.45 P.M 
20.07.14 
10.30 A.M 
  Yes   No No 
350. 1363/14 24 M Married RTA Coolie Treated 20.07.14 
01.00 A.M 
20.07.14 
01.30 P.M 
  Yes   No No 
351. 1366/14 33 M Married Murder Butcher Treated 21.07.14 
05.45 A.M 
21.07.14 
11.40 A.M 
Yes     No No 
352. 1367/14 12 F Single RTA Student Treated 20.07.14 
03.45 P.M 
21.07.14 
01.15 P.M 
  Yes   No No 
353. 1368/14 52 M Married RTA Coolie Treated 20.07.14 
11.25 A.M 
21.07.14 
01.45 P.M 
   Yes  No No 
354. 1369/14 35 M Married RTA Driver Treated 21.07.14 
10.50 A.M 
22.07.14 
11.00 A.M 
   Yes  No No 
355. 1370/14 57 F Married RTA Coolie Treated 21.07.14 
06.55 P.M 
22.07.14 
11.30 A.M 
  Yes   No No 
356. 1375/14 9 M Single Suspicious 
Death 
Student Treated 21.07.14 
02.15 P.M 
22.07.14 
03.15 P.M 
   Yes  No No 
357. 1376/14 52 M Single Natural Coolie Treated 22.07.14 
11.05 A.M 
23.07.14 
10.30 A.M 
  Yes   No No 
358. 1383/14 40 M Married Hanging Coolie Treated 23.07.14 
08.50 P.M 
24.07.14 
01.10 P.M 
  Yes   No No 
359. 1384/14 60 M Married RTA Coolie Treated 24.07.14 
05.30 A.M 
24.07.14 
01.40 P.M 
 Yes    No No 
360. 1387/14 54 M Married RTA Coolie Treated 25.07.14 
01.40 A.M 
25.07.14 
12 Noon 
 Yes    No No 
361. 1388/14 19 M Single TTA  Coolie Treated 24.07.14 
07.20 A.M 
25.07.14 
12.10 A.M 
   Yes  No No 
362. 1391/14 70 F Married RTA Farmer Treated 24.07.14 
12.10 P.M 
25.07.14 
02.40 P.M 
   Yes  No No 
363. 1398/14 72 M Married RTA Private Treated 25.07.14 
05.30 P.M 
26.07.14 
11.15A.M 
  Yes   No No 
364. 1399/14 52 
 
M Married RTA Private Treated 25.07.14 
07.55 A.M 
26.07.14 
11.50 A.M 
   Yes  No No 
365. 1401/14 33 M Married Natural Coolie Treated 25.07.14 
01.10 P.M 
26.07.14 
01.30 P.M 
   Yes   No No 
366. 1403/14 27 F Married Natural Coolie Treated 25.07.14 
10.00 P.M 
26.07.14 
03.30 P.M 
  Yes   No No 
367. 1405/14 38 M Married Fall Mason Treated 25.07.14 
09.30 P.M 
26.07.14 
03.30 P.M 
  Yes   No No 
368. 1406/14 35 M Married Natural  Coolie Brought 
dead 
25.07.14 
10.45 P.M 
26.07.14 
04.00 P.M 
  Yes   No No 
369. 1408/14 42 M Married Poisoning Coolie Treated 25.07.14 
06.55 P.M 
26.07.14 
04.00 P.M 
  Yes   No No 
370. 1409/14 23 M Married RTA Coolie Treated 26.07.14 
03.45 P.M 
27.07.14 
11.00 A.M 
  Yes   No No 
371. 1410/14 42 M Married Natural Coolie Treated 25.07.14 
07.15 P.M 
27.07.14 
12 Noon 
    Yes No No 
372. 1411/14 65 M Married RTA Coolie Treated 26.07.14 
05.15 P.M 
27.07.14 
12.30 P.M 
  Yes   No No 
373. 1412/14 09 M Single Natural  Kid Brought 
dead 
26.07.14 
03.00 P.M 
27.07.14 
01.00 P.M 
  Yes   No No 
374. 1414/14 59 M Married RTA Coolie Treated 27.07.14 
01.30 A.M 
27.07.14 
01.10 P.M 
 Yes    No No 
375. 1415/14 24 M Married Hanging Coolie Treated 27.07.14 
06.50 A.M 
27.07.14 
02.00 P.M 
 Yes    No No 
376. 1416/14 49 M Married RTA Coolie Treated 27.07.14 
01.30 A.M 
27.07.14 
01.40 P.M 
  Yes   No No 
377. 1418/14 
 
65 M Married RTA Coolie Treated 27.07.14 
10.30 P.M 
28.07.14 
11.30A.M 
  Yes   No No 
378. 1421/14 
 
22 M Single RTA Private Treated 27.07.14 
02.30 P.M 
28.07.14 
02.00 P.M 
  Yes   No No 
379. 1422/14 47 M Married Fall Coolie Treated 27.07.14 
06.30 P.M 
28.07.14 
02.30 P.M 
  Yes   No No 
380. 1423/14 18 M Single RTA Student Treated 27.07.14 
05.50 P.M 
28.07.14 
02.30 P.M 
  Yes   No No 
381. 1424/14 28 M Married Natural Coolie Treated 28.07.14 
03.50A.M 
28.07.14 
02.40 P.M 
 Yes     No No 
382. 1426/14 
 
55 F Married Drowning Coolie Treated 28.07.14 
08.30 A.M 
29.07.14 
11.00A.M 
   Yes  No No 
383. 1427/14 
 
46 M Married Fall Plumber Treated 28.07.14 
12.10 P.M 
29.07.14 
11.40A.M 
  Yes   No No 
384. 1428/14 
 
55 M Married Drowning Farmer Treated 28.07.14 
04.50 P.M 
29.07.14 
01.00 P.M 
  Yes   No No 
385. 1429/14 
 
42 M Married RTA Driver Treated 28.07.14 
06.45 P.M 
29.07.14 
12.15 P.M 
  Yes   No No 
386. 1430/14 
 
45 M Married Natural Coolie Treated 28.07.14 
12.30.P.M 
29.07.14 
01.00 P.M 
   Yes  No No 
387. 1431/14 
 
47 M Married Hanging Coolie Treated 28.07.14 
11.45 P.M 
29.07.14 
01.15 P.M 
  Yes   No No 
388. 1433/14 
 
35 F Married Snake Bite House wife Treated 29.07.14 
07.30A.M 
29.07.14 
01.30P.M 
 
29.07.14 
02.30P.  
29.07.14 
01.30P.M 
 
 Yes    No No 
389. 1434/14 
 
35 M Married RTA Coolie Treated 29.07.14 
06.45A.M 
30.07.14 
10.30 A.M 
   Yes  No No 
390. 1437/14 71 M Married RTA Private Treated 30.07.14 
06.40 A.M 
30.07.14 
02.00 P.M 
 Yes    No No 
391. 1438/14 7 F Single RTA  Student Brought 
dead 
29.07.14 
04.20 P.M 
30.07.14 
03.30 P.M 
  Yes   No No 
392. 1440/14 63 F Married RTA House wife Treated 31.07.14 
12.30 A.M 
31.07.14 
02.40 P.M 
  Yes   No No 
393. 1441/14 58 M Married RTA Coolie Treated 31.07.14 
09.50 P.M 
01.08.14 
11.40 A.M 
  Yes`   No No 
394. 1442/14 36 M Married RTA Mason Treated 31.07.14 
11.30 A.M 
01.08.14 
03.30 P.M 
   Yes   No No 
395. 1451/14 45 
 
M Married Hanging Coolie Treated 01.08.14 
02.45P.M 
02.08.14 
12.40P.M 
  Yes   No No 
396. 1453/14 59 M Married  RTA Private Treated 02.08.14 
09.45 A.M 
02.08.14 
04.15 P.M 
 Yes    No No 
397. 1454/14 56 
 
M Married RTA Private Treated 03.08.14 
03.15 A.M 
03.08.14 
11.15 A.M 
 Yes    No No 
398. 1455/14 75 F Married RTA House wife Treated 02.08.14 
05.30 P.M 
03.08.14 
11.45 P.M 
  Yes   No No 
399. 1456/14 21 M Single RTA  Cleaner Brought 
dead 
03.08.14 
04.30 P.M 
04.08.14 
10.30 A.M 
  Yes   No Yes 
400. 1457/14 59 M Married RTA  House wife Brought 
dead 
03.08.14 
01.20 P.M 
04.08.14 
10.40 A.M 
  Yes   No No 
401. 1458/14 28 M Single RTA Driver Treated 04.08.14 
02.30 A.M 
04.08.14 
11.00 A.M 
 Yes    No No 
402. 1459/14 50 M Married  Natural Coolie Treated 02.08.14 
12.30 A.M 
04.08.14 
11.30 A.M 
    Yes No No 
403. 1461/14 26 M Married RTA Coolie Treated 04.08.14 
06.05 A.M 
04.08.14 
12.30 P.M 
 Yes    No No 
404. 1462/14 45 M Married Natural Private Treated 04.08.14 
08.30 A.M 
04.08.14 
02.00 P.M 
Yes      No No 
405. 1463/14 46 M Married RTA Private Treated 04.08.14 
02.00 A.M 
04.08.14 
03.30 P.M 
  Yes   No No 
406. 1464/14 34 
 
M Married RTA Coolie Treated 04.08.14 
07.15 A.M 
04.08.14 
04.30 P.M 
 Yes    No No 
407. 1465/14 42 
 
M Married TTA Private Treated 02.08.14 
07.45 A.M 
05.08.14 
10.30 A.M 
    Yes No No 
408. 1468/14 21 M Married RTA Coolie Treated 04.08.14 05.08.14    Yes  No No 
12.15 P.M 12.40 P.M 
409. 1469/14 27 M Single Hanging Driver Treated 05.08.14 
03.00 A.M 
05.08.14 
01.15 P.M 
 Yes    No No 
410. 1474/14 54 M Married Fall Private Treated 05.08.14 
07.25 A.M 
05.08.14 
04.00 P.M 
 Yes    No No 
411. 1475/14 43 M Married RTA Private Treated 04.08.14 
09.25 P.M 
05.08.14 
04.15 P.M 
  Yes   No No 
412. 1476/14 38 M Married Poisoning Coolie Treated 04.08.14 
01.15 P.M 
05.08.14 
04.10 P.M 
   Yes  No No 
413. 1477/14 43 
 
M Married RTA  Private Brought 
dead 
04.08.14 
07.45 P.M 
05.08.14 
04.30 P.M 
  Yes   No No 
414. 1480/14 53 M Single Fall Private Treated 05.08.14 
07.00 A.M 
06.08.14 
11.30 A.M 
   Yes  No No 
415. 1481/14 17 M Single RTA Student Treated 06.08.14 
05.40 A.M 
06.08.14 
01.40 P.M 
 Yes    No No 
416. 1483/14 44 M Married RTA Driver Treated 06.08.14 
12.15 P.M 
07.08.14 
11.30 A.M 
   Yes  No No 
417. 1484/14 24 M Married Murder Coolie Treated 06.08.14 
09.30 A.M 
07.08.14 
12.30 P.M 
   Yes  No No 
418. 1486/14 68 M Married Natural Coolie Treated 06.08.14 
03.30 P.M 
07.08.14 
02.00 P.M 
  Yes   No No 
419. 1488/14 42 M Married Fall Coolie Treated 07.08.14 
12.05 A.M 
07.08.14 
03.30 P.M 
 Yes    No No 
420. 1489/14 55 M Married Natural Coolie Treated 07.08.14 
05.30 A.M 
07.08.14 
03.30 P.M 
 Yes    No No 
421. 1490/14 24 M Single Poisoning Govt Treated 07.08.14 
06.00 A.M 
07.08.14 
03.40 P.M 
 Yes    No No 
422. 1491/14 60 F Married RTA House wife Brought 
dead 
07.08.14 
08.40 A.M 
08.08.14 
11.00 A.M 
   Yes  No No 
423. 1492/14 37 M Married RTA  Farmer Brought 
dead 
07.08.14 
09.00 A.M 
08.08.14 
11.00 A.M 
   Yes  No No 
424. 1494/14 23 F Married RTA Coolie Treated 07.08.14 
09.45 A.M 
08.08.14 
01.00 P.M 
   Yes  No No 
425. 1496/14 25 M Single RTA Coolie Treated 07.08.14 
03.50 P.M 
08.08.14 
02.30 P.M 
  Yes   No No 
426. 1498/14 22 M Single TTA  Student Brought 09.08.14 09.08.14 Yes     No No 
dead 08.00 A.M 11.00 A.M 
427. 1499/14 45 F Married TTA  Merchant Brought 
dead 
08.08.14 
09.45 A.M 
09.08.14 
11.30 A.M 
   Yes  No Yes 
428. 1500/14 47 M Married Natural Private Treated 08.08.14 
06.15 P.M 
09.08.14 
11.00 A.M 
  Yes   No No 
429. 1502/14 50 M Married RTA Coolie Treated 08.08.14 
10.45 P.M 
09.08.14   
12.30 P.M 
  Yes   No No 
430. 1503/14 26 M Single RTA  Private Brought 
dead 
08.08.14 
03.30 P.M 
09.08.14 
01.00 P.M 
  Yes   No No 
431. 1505/14 42 M Married RTA Driver Treated 09.08.14 
05.00 A.M 
09.08.14 
03.00 P.M 
 Yes    No No 
432. 1506/14 29 M Married Natural Coolie Treated 09.08.14 
08.30 A.M 
09.08.14 
03.15 P.M 
 Yes    No No 
433. 1507/14 14 M Single Scorpion 
Bite  
Student Brought 
dead 
08.08.14 
08.05 P.M 
09.08.14 
03.40 P.M 
  Yes   No No 
434. 1508/14 59 M Married RTA Private Treated 09.08.14 
05.10 P.M 
10.08.14 
10.15 A.M 
  Yes   No No 
435. 1509/14 20 M Single RTA Private Treated 09.08.14 
07.50 A.M 
10.08.14 
11.00 A.M 
   Yes  No No 
436. 1510/14 52 F Married RTA House wife Treated 10.08.14 
02.30 A.M 
10.08.14 
11.30 A.M 
 Yes    No No 
437. 1511/14 22 M Single Natural Private Treated 10.08.14 
07.15 A.M 
10..08.14 
01.00 P.M 
Yes     No No 
438. 1512/14 70 M Married Fall Coolie Treated 10.08.14 
07.40 A.M 
10.08.14 
03.30 P.M 
 Yes    No No 
439. 1513/14 45 M Married Poisoning Coolie Treated 10.08.14 
07.25 P.M 
11.08.14 
01.00 P.M 
  Yes   No No 
440. 1514/14 23 
 
M Single Accident Coolie Treated 09.08.14 
02.30 P.M 
11.08.14 
01.15 P.M 
    Yes No No 
441. 1516/14 45 M Married Poisoning Coolie Treated 11.08.14 
02.25 P.M 
12.08.14 
12.30 P.M 
  Yes   No No 
442. 1517/14 24 M Married RTA Private Treated 10.08.14 
10.45 P.M 
12.08.14 
12.30 P.M 
    Yes No No 
443. 1518/14 61 M Married RTA Private Treated 11.08.14 
11.20 P.M 
12.08.14 
12.40 P.M 
  Yes   No No 
444. 1520/14 40 M Married RTA Painter Treated 12.08.14 12.08.14  Yes    No No 
04.30 A.M 01.15 P.M 
445. 1521/14 56 M Married Murder Coolie Treated 12.08.14 
07.00 A.M 
12.08.14 
03.40 P.M 
 Yes    No No 
446. 1522/14 40 M Married RTA Coolie Treated 12.08.14 
11.00 P.M 
13.08.14 
11.30 A.M 
  Yes   No No 
447. 1523/14 62 M Married Hanging Private Treated 12.08.14 
01.45 P.M 
13.08.14 
11.30 A.M 
  Yes   No No 
448. 1524/14 22 M Single TTA Coolie Treated 12.08.14 
06.50 P.M 
13.08.14 
12.30 P.M 
  Yes   No No 
449. 1526/14 22 
 
M Single RTA Coolie Treated 13.08.14 
05.20 A.M 
13.08.14 
01.40 A.M 
 Yes    No No 
450. 1527/14 28 M Single Fall Coolie Treated 12.08.14 
10.00 A.M 
13.08.14 
02.30 P.M 
   Yes  No No 
451. 1528/14 42 
 
M Married RTA Coolie Treated 12.08.14 
10.20 P.M 
13.08.14 
02.40 P.M 
  Yes   No No 
452. 1529/14 30 
 
M Single RTA Coolie Treated 12.08.14 
06.45 P.M 
13.08.14 
03.30 P.M 
  Yes   No No 
453. 1530/14 60 M Married RTA Painter Treated 13.08.14 
05.15 A.M 
13.08.14 
03.30 P.M 
 Yes    No No 
454. 1531/14 80 M Married Natural Coolie Treated 13.08.14 
02.00 P.M 
14.08.14 
01.00 P.M 
  Yes   No No 
455. 1533/14 40 M Married Natural Merchant Treated 13.08.14 
09.20 P.M 
14.08.14 
01.30 P.M 
  Yes   No No 
456. 1534/14 50 M Married RTA  Coolie Brought 
dead 
13.08.14 
06.10 P.M 
14.08.14 
02.00 P.M 
  Yes   No No 
457. 1535/14 30 M Married RTA Driver Treated 14.08.14 
09.30 A.M 
15.08.14 
10.15 A.M 
   Yes  No No 
458. 1536/14 30 M Single Poisoning Coolie Treated 14.08.14 
09.00 A.M 
15.08.14 
11.30 A.M 
   Yes  No No 
459. 1537/14 34 M Single Poisoning Coolie Treated 14.08.14 
10.50 P.M 
15.08.14 
12.10 P.M 
  Yes   No No 
460. 1538/14 45 M Married Natural Coolie Treated 14.08.14 
09.30 P.M 
15.08.14 
01.30 P.M 
  Yes   No No 
461. 1539/14 39 M Married Fall Coolie Treated 14.08.14 
09.45 P.M 
15.08.14 
02.30 P.M 
  Yes   No No 
462. 1540/14 27 M Single Poisoning Coolie Treated 14.08.14 15.08.14   Yes   No No 
02.40 P.M 02.30 P.M 
463. 1541/14 60 M Married Fall  Private Brought 
dead 
15.08.14 
08.20 A.M 
15.08.14 
02.30 P.M 
 Yes    No No 
464. 1542/14 68 M Married Natural Coolie Treated 15.08.14 
08.50 A.M 
15.08.14 
03.00 P.M 
 Yes    No No 
465. 1543/14 26 M Married Electrocut
ion 
Coolie Treated 15.08.14 
03.00 A.M 
15.08.14 
03.30 P.M 
  Yes   No No 
466. 1575/14 48 M Married TTA Private Treated 20.08.14 
12.50 P.M 
20.08.14 
02.30 P.M 
Yes     No No 
467. 1620/14 2 F Single Poisoning Kid Treated 27.08.14 
02.45 P.M 
27.08.14 
04.00 P.M 
Yes     No No 
468. 1622/14 43 M Single Murder  Lawyer Brought 
dead 
28.08.14 
03.22 A.M 
28.08.14 
11.40 A.M 
 Yes    No No 
469. 1625/14 25 M Married RTA Private Treated 28.08.14 
04.30 P.M 
29.08.14 
12.30 P.M 
  Yes   No No 
470. 1628/14 51 M Married RTA Coolie Treated 28.08.14 
03.40 P.M 
29.08.14 
03.00 P.M 
  Yes   No No 
471. 1629/14 6 
mo
nth
s 
M Single Fall Kid Treated 28.08.14 
09.20 A.M 
29.08.14 
04.30 P.M 
    Yes No No 
472. 1652/14 35 M Single RTA Driver Treated 31.08.14 
10.15 P.M 
01.09.14 
03.30 P.M 
  Yes   No No 
473. 1656/14 60 M Married RTA Private Treated 02.09.14 
04.00 A.M 
02.09.14 
11.30 A.M 
 Yes    No No 
474. 1657/14 40 M Married TTA Merchant Treated 01.09.14 
07.20 P.M 
02.09.14 
12.30 P.M 
  Yes   No No 
475. 1658/14 78 M Married RTA Coolie Treated 01.09.14 
03.15 P.M 
02.09.14 
01.30 P.M 
  Yes   No No 
476. 1659/14 64 F Married RTA Merchant Treated 02.09.14 
01.50 A.M 
02.09.14 
01.30 P.M 
 Yes    No No 
477. 1660/14 50 F Married RTA House wife Treated 02.09.14 
01.50 A.M 
02.09.14 
02.40 P.M 
  Yes   No No 
478. 1662/14 
 
49 M Married RTA Coolie Treated 02.09.14 
11.30 A.M 
02.09.14 
04.00 P.M 
Yes     No No 
479. 1663/14 57 M Married RTA Coolie Treated 02.09.14 03.09.14   Yes   No No 
02.45 P.M 11.00 A.M 
480. 1664/14 
 
16 M Single Drowning Student Treated 02.09.14 
11.15 A.M 
03.09.14 
11.00 A.M 
  Yes   No No 
481. 1665/14 
 
35 M Married RTA Coolie Treated 03.09.14 
12.40 A.M 
03.09.14 
02.00 P.M 
  Yes   No No 
482. 1666/14 
 
21 M Single TTA Student Treated 03.09.14 
07.15 A.M 
03.09.14 
04.00 P.M 
 Yes    No No 
483. 1667/14 
 
32 M Single TTA Coolie Treated 03.09.14 
04.50 P.M 
04.09.14 
11.00 A.M 
  Yes   No No 
484. 1668/14 
 
50 M Married RTA Govt Treated 03.09.14 
10.40 A.M 
04.09.14 
11.30 A.M 
   Yes  No No 
485. 1669/14 32 M Married RTA  Farmer Brought 
dead 
03.09.14 
07.55 P.M 
04.09.14 
11.30 A.M 
  Yes   No No 
486. 1671/14 42 F Married Murder Coolie Treated 03.09.14 
10.20 A.M 
04.09.14 
01.00 P.M 
   Yes  No No 
487. 1672/14 40 M Married Fall  Coolie Treated 03.09.14 
11.45 A.M 
04.09.14 
01.30 P.M 
   Yes  No No 
488. 1677/14 
 
25 M Married TTA  Private Brought 
dead 
05.09.14 
05.00 A.M 
05.09.14 
12.30 P.M 
 Yes    No No 
489. 1678/14 49 M Married Fall Govt Treated 04.09.14 
04.15 P.M 
05.09.14 
03.00 P.M 
  Yes   No No 
490. 1681/14 25 M Single RTA Private Treated 05.09.14 
 01.15P.M 
06.09.14 
10.15 A.M 
  Yes   No No 
491. 1683/14 60 F Married RTA  Private Brought 
dead 
04.09.14 
06.10 A.M 
06.09.14 
01.00 P.M 
    Yes No No 
492. 1684/14 40 F NK TTA NK Treated 05.08.14 
05.30 P.M 
06.09.14 
01.30 P.M 
  Yes   No No 
493. 1685/14 55 M Single Electrocut
ion 
Coolie Treated 06.09.14 
12.50 A.M 
06.09.14 
01.40 P.M 
  Yes   No No 
494. 1687/14 67 F Married Natural Coolie Treated 05.09.14 
10.30 P.M 
06.09.14 
02.30 P.M 
  Yes   No No 
495. 1688/14 
 
62 M Married RTA Coolie Treated 05.09.14 
10.15 P.M 
06.09.14 
03.30 P.M 
  Yes   No No 
496. 1689/14 
 
26 M Single Fall Mechanic Treated 06.09.14 
09.30 A.M 
07.09.14 
11.00 A.M 
   Yes  No No 
497. 1690/14 46 M Married Natural Coolie Treated 06.09.14 07.09.14   Yes   No Yes 
 05.55 P.M 11.50 A.M 
498. 1691/14 
 
39 M Married Industrial 
accident 
Coolie Treated 06.09.14 
10.05 P.M 
07.09.14 
12.45 P.M 
  Yes   No No 
499. 1694/14 45 M Married Poisoning Driver  
 
Treated 07.09.14 
08.00 A.M 
08.09.14  
10.45 A.M 
   Yes  No No 
500. 1695/14 45 M Married Electrocut
ion 
Coolie Treated 07.09.14 
08.30 A.M 
08.09.14 
11.00 A.M 
   Yes  No No 
501. 1696/14 45 M Married Fall Coolie Treated 07.09.14 
12.15 A.M 
08..09.14 
03.30 P.M 
    Yes No No 
502. 1699/14 
 
70 M Married Poisoning Coolie Treated 08.09.14 
12.10 P.M 
09.09.14 
11.40 A.M 
  Yes   No No 
503. 1703/14 
 
38 M Married Natural Coolie Treated 08.09.14 
08.20 A.M 
09.09.14 
01.30 P.M 
   Yes  No No 
504. 1707/14 26 M Married RTA Coolie Treated 08.09.14 
06.00 A.M 
09.09.14 
02.30 P.M 
   Yes  No No 
505. 1709/14 30 M Single TTA Coolie Treated 06.09.14 
03.30 P.M 
10.09.14 
12.15 P.M 
    Yes No No 
506. 1712/14 45 M Married RTA Coolie Treated 09.09.14 
01.10 P.M 
10.09.14 
01.30 P.M 
   Yes  No No 
507. 1713/14 75 F Married Poisoning House wife Treated 10.09.14 
01.15 A.M 
10.09.14 
03.00 P.M 
  Yes   No No 
508. 1714/14 34 M Married RTA Coolie Treated 10.09.14 
12.45 A.M 
10.09.14 
04.00 P.M 
  Yes   No No 
509. 1715/14 43 M Married RTA Private Treated 10.09.14 
12.13 P.M 
11.09.14 
10.40 A.M 
  Yes   No No 
510. 1716/14 
 
50 M Married RTA Govt  Treated 10.09.14 
03.55 P.M 
11.09.14 
11.00 A.M 
  Yes   No No 
511. 1718/14 50 F Married Natural House wife Treated 10.09.14 
07.00 P.M 
11.09.14 
11.40 A.M 
  Yes   No No 
512. 1719.14 64 F Married RTA Coolie Treated 10.09.14 
11.00 P.M 
11.09.14 
02.00 P.M 
  Yes   No No 
513. 1720/14 42 M Single RTA Coolie Treated 10.09.14 
11.15 A.M 
11.09.14 
02.15 P.M 
   Yes  No No 
514. 1721/14 80 F Married Poisoning House wife Treated 10.09.14 
06.15 P.M 
11.09.14 
02.00 P.M 
  Yes   No No 
515. 1722/14 60 M Married RTA Coolie Treated 10.09.14 11.09.14   Yes   No No 
 Abbreviations:  
1. P.M No – Post mortem number 
2. M – Male 
3. F – Female 
4. RTA – Road Traffic Accident 
5. TTA – Train Traffic Accident 
6. NK – Not Known 
7. HBV – Hepatitis B Virus 
8. HBsAg – Hepatitis B Surface antigen 
 
 
04.30 P.M 02.30 P.M 
